CAMPUS CREST COMMUNITIES, INC. Shares of Common Stock Underwriting Agreement
Exhibit 1.1
Shares of Common Stock
, 2010
Xxxxxxx Xxxxx & Associates, Inc.
000 Xxxxxxxx Xxxxxxx
Xx. Xxxxxxxxxx, Xxxxxxx 00000
000 Xxxxxxxx Xxxxxxx
Xx. Xxxxxxxxxx, Xxxxxxx 00000
Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxxx, Sachs & Co.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Barclays Capital Inc.
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
RBC Capital Markets Corporation
Three World Financial Center, 8th Floor
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Three World Financial Center, 8th Floor
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
As Representatives of the
several Underwriters listed
in Schedule 1 hereto
several Underwriters listed
in Schedule 1 hereto
Ladies and Gentlemen:
Campus Crest Communities, Inc., a Maryland corporation (the “Company”), proposes to issue and
sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are
acting as representatives (the “Representatives”), an aggregate of shares of common
stock, $0.01 par value per share, of the Company (the “Underwritten Shares”) and, at the option of
the Underwriters, up to an additional shares of common stock of the Company (the
“Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the
“Shares.” The shares of common stock of the Company to be outstanding after giving effect to the
sale of the Shares are referred to herein as the “Stock.”
As part of the offering contemplated by this Agreement, and subject to the terms of this
Agreement, the applicable rules, regulations and interpretations of the Financial Industry
Regulatory Authority, Inc. (“FINRA”) and all other applicable laws, rules and regulations, the
Underwriters have agreed at our request to reserve out of the Shares set forth opposite their names
on Schedule 1 to this Agreement, up to Shares, for sale to certain of the Company’s
directors, officers, employees and certain other persons associated with the Company (collectively,
“Participants”). The Shares to be sold by or on behalf of the Underwriters to the Participants (the
“Directed Shares”) will be sold pursuant to this Agreement at
1
the public offering price (the “Directed Share Program”). Any Directed Shares not orally confirmed for
purchase by any Participant by 9:00 A.M., New York City time, on the business day immediately
following the date on which this Agreement is executed will be offered to the public with the
remaining Shares.
At the Closing Date (as defined below), the Company, through its subsidiary, Campus Crest
Communities Operating Partnership, LP, a Delaware limited partnership and the operating partnership
of the Company (in such capacity, the “Operating Partnership”), will acquire direct or indirect
ownership interests in the 27 properties (the “Initial Properties”) identified on Annex C hereto
and in furtherance of acquiring such ownership interests and the transactions described in the
Registration Statement, Pricing Disclosure Package and Prospectus (each as defined below), the
Company and the Operating Partnership has entered into, or will enter into, as of the Closing Date,
as the case may be, the agreements indentified on Annex D hereto. Those agreements are hereinafter
collectively referred to as the “Transaction Documents” and singly as a “Transaction Document.”
The Company and the Operating Partnership each hereby confirms its agreement with the several
Underwriters concerning the purchase and sale of the Shares, as follows:
1. Registration Statement. The Company has prepared and filed with the Securities and
Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the “Securities Act”), a registration
statement on Form S-11 (File No. 333-166834), including a prospectus, relating to the Shares. Such
registration statement, as amended at the time it became effective, including the information, if
any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the
registration statement at the time of its effectiveness (“Rule 430 Information”), is referred to
herein as the “Registration Statement”; and as used herein, the term “Preliminary Prospectus” means
each prospectus included in such registration statement (and any amendments thereto) before it
becomes effective that is furnished by the Company to the Underwriters for distribution in
connection with the offering of the Shares, any prospectus filed with the Commission pursuant to
Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at
the time of such Registration Statement’s effectiveness that omits Rule 430 Information; and the
term “Prospectus” means the prospectus in the form first used (or made available upon request of
purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales
of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule
462(b) under the Securities Act (the “Rule 462 Registration Statement”), then any reference herein
to the term “Registration Statement” shall be deemed to include such Rule 462 Registration
Statement. Capitalized terms used but not defined herein shall have the meanings given to such
terms in the Registration Statement and the Prospectus.
At or prior to the Applicable Time (as defined below), the Company had prepared the following
information (collectively with the pricing information set forth on Annex B, the “Pricing
Disclosure Package”): a Preliminary Prospectus dated , 2010 and each “free-writing
prospectus” (as defined pursuant to Rule 405 under the Securities Act) listed on Annex B hereto.
“Applicable Time” means , New York City time, on , 2010.
2. Purchase of the Shares by the Underwriters.
(a) The Company agrees to issue and sell the Underwritten Shares to the several
Underwriters as provided in this Agreement, and each Underwriter, on the basis of the
representations, warranties and agreements set forth herein and subject to the conditions
set forth herein, agrees, severally and not jointly, to purchase from the Company the
respective number of
2
Underwritten Shares set forth opposite such Underwriter’s name in Schedule 1 hereto at
a price per share (the “Purchase Price”) of $.
In addition, the Company agrees to issue and sell the Option Shares to the several
Underwriters as provided in this Agreement, and the Underwriters, on the basis of the
representations, warranties and agreements set forth herein and subject to the conditions
set forth herein, shall have the option to purchase, severally and not jointly, from the
Company the Option Shares at the Purchase Price less an amount per share equal to any
dividends or distributions declared by the Company after the date hereof and prior to the
issuance of the Option Shares and payable on the Underwritten Shares but not payable on the
Option Shares.
If any Option Shares are to be purchased, the number of Option Shares to be purchased
by each Underwriter shall be the number of Option Shares which bears the same ratio to the
aggregate number of Option Shares being purchased as the number of Underwritten Shares set
forth opposite the name of such Underwriter in Schedule 1 hereto (or such number increased
as set forth in Section 10 hereof) bears to the aggregate number of Underwritten Shares
being purchased from the Company by the several Underwriters, subject, however, to such
adjustments to eliminate any fractional Shares as the Representatives in their sole
discretion shall make.
The Underwriters may exercise the option to purchase Option Shares at any time in
whole, or from time to time in part, on or before the thirtieth day following the date of
the Prospectus, by written notice from the Representatives to the Company. Such notice
shall set forth the aggregate number of Option Shares as to which the option is being
exercised and the date and time when the Option Shares are to be delivered and paid for,
which may be the same date and time as the Closing Date (as hereinafter defined) but shall
not be earlier than the Closing Date or later than the tenth full business day (as
hereinafter defined) after the date of such notice (unless such time and date are postponed
in accordance with the provisions of Section 10 hereof). Any such notice shall be given at
least two business days prior to the date and time of delivery specified therein.
(b) The Company understands that the Underwriters intend to make a public offering of
the Shares as soon after the effectiveness of this Agreement as in the judgment of the
Representatives is advisable, and initially to offer the Shares on the terms set forth in
the Prospectus. The Company acknowledges and agrees that the Underwriters may offer and
sell Shares to or through any affiliate of an Underwriter.
(c) Payment for the Shares shall be made by wire transfer in immediately available
funds to the account specified by the Company to the Representatives in the case of the
Underwritten Shares, at the offices of Sidley Austin llp, 000 Xxxxxxx Xxxxxx, Xxx
Xxxx, XX 00000 at 10:00 A.M., New York City time, on , 2010, or at such other
time or place on the same or such other date, not later than the fifth business day
thereafter, as the Representatives and the Company may agree upon in writing or, in the case
of the Option Shares, on the date and at the time and place specified by the Representatives
in the written notice of the Underwriters’ election to purchase such Option Shares. The
time and date of such payment for the Underwritten Shares is referred to herein as the
“Closing Date,” and the time and date for such payment for the Option Shares, if other than
the Closing Date, is herein referred to as the “Additional Closing Date.”
Payment for the Shares to be purchased on the Closing Date or the Additional Closing
Date, as the case may be, shall be made against delivery to the Representatives for the
respective accounts of the several Underwriters of the Shares to be purchased on such date,
with any transfer
3
taxes payable in connection with the sale of such Shares duly paid by the Company.
Delivery of the Shares shall be made through the facilities of The Depository Trust Company
(“DTC”) unless the Representatives shall otherwise instruct. The certificates for the
Shares, if any, will be made available for inspection and packaging by the Representatives
at the office of DTC or its designated custodian not later than 1:00 P.M., New York City
time, on the business day prior to the Closing Date or the Additional Closing Date, as the
case may be.
(d) Each of the Company and the Operating Partnership acknowledge and agree that the
Underwriters are acting solely in the capacity of an arm’s-length contractual counterparty
to the Company and the Operating Partnership with respect to the offering of Shares
contemplated hereby (including in connection with determining the terms of the offering) and
not as a financial advisor or a fiduciary to, or an agent of, the Company, the Operating
Partnership or any other person. Additionally, neither the Representatives nor any other
Underwriter is advising the Company, the Operating Partnership or any other person as to any
legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company
and the Operating Partnership shall consult with their own advisors concerning such matters
and shall be responsible for making their own independent investigation and appraisal of the
transactions contemplated hereby, and the Underwriters shall have no responsibility or
liability to the Company or the Operating Partnership with respect thereto. Any review by
the Underwriters of the Company, the Operating Partnership, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the
benefit of the Underwriters and shall not be on behalf of the Company or the Operating
Partnership.
3. Representations and Warranties of the Company and the Operating Partnership. Each
of the Company and the Operating Partnership, jointly and severally, represents and warrants to
each Underwriter that:
(a) Preliminary Prospectus. No order preventing or suspending the use of any
Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus
included in the Pricing Disclosure Package, at the time of filing thereof, complied in all
material respects with the Securities Act, and no Preliminary Prospectus, at the time of
filing thereof, contained any untrue statement of a material fact or omitted to state a
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided that neither the
Company nor the Operating Partnership makes any representation and warranty with respect to
any statements or omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use in any Preliminary Prospectus, it being understood and
agreed that the only such information furnished by any Underwriter consists of the
information described as such in Section 7(b) hereof.
(b) Pricing Disclosure Package. The Pricing Disclosure Package as of the Applicable
Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case
may be, will not, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided that neither the
Company nor the Operating Partnership makes any representation and warranty with respect to
any statements or omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use in such Pricing Disclosure Package, it being
understood and agreed that the only such information furnished by any Underwriter consists
of the information described as such in Section 7(b) hereof.
4
(c) Issuer Free Writing Prospectus. Other than the Registration Statement, the
Preliminary Prospectus and the Prospectus, the Company (including its agents and
representatives, other than the Underwriters in their capacity as such) has not prepared,
used, authorized, approved or referred to and will not prepare, use, authorize, approve or
refer to any “written communication” (as defined in Rule 405 under the Securities Act) that
constitutes an offer to sell or solicitation of an offer to buy the Shares (each such
communication by the Company or its agents and representatives (other than a communication
referred to in clause (i) below) an “Issuer Free Writing Prospectus”) other than (i) any
document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act
or Rule 134 under the Securities Act or (ii) the documents listed on Annex B hereto, each
electronic road show and any other written communications approved in writing in advance by
the Representatives. Each such Issuer Free Writing Prospectus complied in all material
respects with the Securities Act, has been or will be (within the time period specified in
Rule 433 under the Securities Act) filed in accordance with the Securities Act (to the
extent required thereby) and, when taken together with the Preliminary Prospectus
accompanying, or delivered prior to delivery of, such Issuer Free Writing Prospectus, did
not, and as of the Closing Date and as of the Additional Closing Date, as the case may be,
will not, contain any untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading; provided that neither the Company nor the
Operating Partnership makes any representation and warranty with respect to any statements
or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in
reliance upon and in conformity with information relating to any Underwriter furnished to
the Company in writing by such Underwriter through the Representatives expressly for use in
such Issuer Free Writing Prospectus or Preliminary Prospectus, it being understood and
agreed that the only such information furnished by any Underwriter consists of the
information described as such in Section 7(b) hereof.
(d) Registration Statement and Prospectus. The Registration Statement has been
declared effective by the Commission. No order suspending the effectiveness of the
Registration Statement has been issued by the Commission, and no proceeding for that purpose
or pursuant to Section 8A of the Securities Act against the Company or related to the
offering of the Shares has been initiated or threatened by the Commission; as of the
applicable effective date of the Registration Statement and any post-effective amendment
thereto, the Registration Statement and any such post-effective amendment complied and will
comply in all material respects with the Securities Act, and did not and will not contain
any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein not misleading; and as
of the date of the Prospectus and any amendment or supplement thereto and as of the Closing
Date and as of the Additional Closing Date, as the case may be, the Prospectus will not
contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading; provided that neither the Company nor the Operating
Partnership makes any representation and warranty with respect to any statements or
omissions made in reliance upon and in conformity with information relating to any
Underwriter furnished to the Company in writing by such Underwriter through the
Representatives expressly for use in the Registration Statement and the Prospectus and any
amendment or supplement thereto, it being understood and agreed that the only such
information furnished by any Underwriter consists of the information described as such in
Section 7(b) hereof. The information in the Registration Statement, the Pricing Disclosure
Package and the Prospectus regarding the Company’s expected 2011 development properties is
accurate and complete in all material respects and the assumptions underlying such
information, including the information regarding targeted completion and estimated cost, are
reasonable.
5
(e) Financial Statements. The financial statements (including the related notes
thereto) of Campus Crest Communities Predecessor (the “Predecessor”) and its consolidated
subsidiaries included in the Registration Statement, the Pricing Disclosure Package and the
Prospectus comply in all material respects with the applicable requirements of the
Securities Act and present fairly (i) the financial position of the Initial Properties (and
certain related assets and liabilities) and (ii) the financial position of the Predecessor
and its consolidated subsidiaries as of the dates indicated and the results of their
operations and the changes in their cash flows for the periods specified; such financial
statements have been prepared in conformity with generally accepted accounting principles in
the United States applied on a consistent basis throughout the periods covered thereby, and
any supporting schedules included in the Registration Statement present fairly the
information required to be stated therein; the other financial and statistical information
included in the Registration Statement, the Pricing Disclosure Package and the Prospectus
has been derived from the accounting records of the Predecessor and its consolidated
subsidiaries and presents fairly the information shown thereby; and the pro forma financial
information and the related notes thereto included in the Registration Statement, the
Pricing Disclosure Package and the Prospectus have been prepared in accordance with the
applicable requirements of the Securities Act and the assumptions underlying such pro forma
financial information are reasonable and are set forth in the Registration Statement, the
Pricing Disclosure Package and the Prospectus. No financial statements are required to be
included in the Registration Statement, the Pricing Disclosure Package or the Prospectus
other than those included therein.
(f) No Material Adverse Change. Since the date of the most recent financial statements
of the Company included in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, (i) there has not been any change in the capital stock (other than the
issuance of restricted shares of Common Stock under the Company’s 2010 Incentive Award Plan
described in the Registration Statement, the Pricing Disclosure Package and the Prospectus
(the “Equity Incentive Plan”)), short-term debt or long-term debt of the Company, the
Operating Partnership or any of their subsidiaries, or any dividend or distribution of any
kind declared, set aside for payment, paid or made by the Company on any class of capital
stock, or any material adverse change, or any development involving a prospective material
adverse change, in or affecting the business, properties, management, financial position,
stockholders’ equity, results of operations or prospects of the Company, the Operating
Partnership and their subsidiaries taken as a whole; (ii) none of the Company, the Operating
Partnership nor any of their subsidiaries has entered into any transaction or agreement
(whether or not in the ordinary course of business) that is material to the Company, the
Operating Partnership and their subsidiaries taken as a whole nor incurred any liability or
obligation, direct or contingent, that is material to the Company, the Operating Partnership
and their subsidiaries taken as a whole; and (iii) none of the Company, the Operating
Partnership nor any of their subsidiaries has sustained any loss or interference with its
business that is material to the Company, the Operating Partnership and their subsidiaries
taken as a whole and that is either from fire, explosion, flood or other calamity, whether
or not covered by insurance, or from any labor disturbance or dispute or any action, order
or decree of any court or arbitrator or governmental or regulatory authority, except in each
case as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package
and the Prospectus.
(g) Organization and Good Standing. The Company, the Operating Partnership and each of
their subsidiaries have been duly organized and are validly existing and in good standing
under the laws of their respective jurisdictions of organization, are duly qualified to do
business and are in good standing in each jurisdiction in which their respective ownership
or lease of property or the conduct of their respective businesses requires such
qualification, and have all power and authority necessary to own, lease, develop and operate
their respective properties
6
(including, without limitation, the Initial Properties) and to conduct the businesses
in which they are engaged, except where the failure to be so qualified or in good standing
or have such power or authority would not, individually or in the aggregate, have a material
adverse effect on the business, properties, management, financial position, stockholders’
equity, results of operations or prospects of the Company, the Operating Partnership and
their subsidiaries taken as a whole, or on the performance by the Company or the Operating
Partnership of their respective obligations under this Agreement or the Transaction
Documents (a “Material Adverse Effect”). The Company does not own or control, directly or
indirectly, any corporation or association or other entity other than the subsidiaries
listed in Exhibit 21 to the Registration Statement (each a “Significant Subsidiary” and
collectively, the “Significant Subsidiaries”).
(h) Capitalization. The Company has an authorized capitalization as set forth in the
Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading
“Capitalization”; all the outstanding shares of capital stock of the Company have been duly
and validly authorized and issued and are fully paid and non-assessable and are not subject
to any pre-emptive or similar rights; except as described in or expressly contemplated in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no
outstanding rights (including, without limitation, pre-emptive rights), warrants or options
to acquire, or instruments convertible into or exchangeable for, any shares of capital stock
or other equity interest in the Company, the Operating Partnership or any of their
subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any
kind relating to the issuance of any capital stock of the Company, the Operating Partnership
or any such subsidiary, any such convertible or exchangeable securities or any such rights,
warrants or options; the capital stock of the Company conforms in all material respects to
the description thereof contained in the Registration Statement, the Pricing Disclosure
Package and the Prospectus; and all the outstanding shares of capital stock or other equity
interests of each subsidiary owned, directly or indirectly, by the Company or the Operating
Partnership have been duly and validly authorized and issued, are fully paid and
non-assessable and are owned directly or indirectly by the Company or the Operating
Partnership, free and clear of any lien, charge, encumbrance, security interest, restriction
on voting or transfer or any other claim of any third party. All the outstanding units of
partnership interests in the Operating Partnership (“OP Units”) have been duly and validly
authorized and issued and are fully paid and non-assessable and are not subject to any
pre-emptive or similar rights. The terms of the OP Units conform in all material respects to
the descriptions thereto contained in the Registration Statement, the Pricing Disclosure
Package and the Prospectus.
(i) Underwriting Agreement. This Agreement has been duly authorized, executed and
delivered by each of the Company and the Operating Partnership.
(j) The Shares. The Shares to be issued and sold by the Company hereunder have been
duly authorized and, when issued and delivered and paid for as provided herein, will be duly
and validly issued, will be fully paid and nonassessable and will conform to the
descriptions thereof in the Registration Statement, the Pricing Disclosure Package and the
Prospectus; and the issuance of the Shares is not subject to any preemptive or similar
rights.
(k) OP Units. The OP Units to be issued by the Operating Partnership in connection
with the Company’s contribution of the net proceeds from the sale of the Shares to the
Operating Partnership or in connection with the contribution of certain ownership interests
in the Initial Properties to the Operating Partnership have been duly authorized and, when
issued and delivered, will be duly and validly issued, will be fully paid and nonassessable
and will conform to the descriptions thereof in the Registration Statement, the Pricing
Disclosure Package and the
7
Prospectus; and the issuance of the OP Units is not subject to any preemptive or
similar rights. In addition, the issuance and sale by the Operating Partnership of the OP
Units in connection with the contribution of the ownership interests in the Initial
Properties to the Operating Partnership are exempt from the registration requirements of the
Securities Act and applicable state securities, real estate syndication and blue sky laws.
(l) Transaction Documents. The Transaction Documents have been, or as of the Closing
Date will be, duly authorized, executed and delivered by each of the Company and the
Operating Partnership and, when duly executed and delivered in accordance with their terms
by the other parties thereto, will constitute valid and legally binding agreements of each
of the Company and the Operating Partnership, enforceable against each of them in accordance
with their terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, fraudulent conveyance or similar laws affecting creditors’ rights generally or
by equitable principles relating to enforceability.
(m) Descriptions of the Transaction Documents. Each Transaction Document conforms in
all material respects to the description thereof contained in the Registration Statement,
the Pricing Disclosure Package and the Prospectus.
(n) No Violation or Default. None of the Company, the Operating Partnership nor any of
their subsidiaries is (i) in violation of its charter or by-laws or similar organizational
documents; (ii) in default, and no event has occurred that, with notice or lapse of time or
both, would constitute such a default, in the due performance or observance of any term,
covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or
other agreement or instrument to which the Company, the Operating Partnership or any of
their subsidiaries is a party or by which the Company, the Operating Partnership or any of
their subsidiaries is bound or to which any of the property or assets of the Company, the
Operating Partnership or any of their subsidiaries is subject; or (iii) in violation of any
law or statute or any judgment, order, rule or regulation of any court or arbitrator or
governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above,
for any such default or violation that is disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus and for which a valid waiver has been obtained
or that would not, individually or in the aggregate, have a Material Adverse Effect.
(o) No Conflicts. The execution, delivery and performance by the Company and the
Operating Partnership of this Agreement, of each of the Transaction Documents, the issuance
and sale of the Shares and the consummation of the transactions contemplated by this
Agreement and the Transaction Documents will not (i) conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a default under, or result in
the creation or imposition of any lien, charge or encumbrance upon any property or assets of
the Company, the Operating Partnership or any of their subsidiaries pursuant to, any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which
the Company, the Operating Partnership or any of their subsidiaries is a party or by which
the Company, the Operating Partnership or any of their subsidiaries is bound or to which any
of the property or assets of the Company, the Operating Partnership or any of their
subsidiaries is subject, (ii) result in any violation of the provisions of the charter or
by-laws or similar organizational documents of the Company, the Operating Partnership or any
of their subsidiaries or (iii) result in the violation of any law or statute or any
judgment, order, rule or regulation of any court or arbitrator or governmental or
regulatory authority, except, in the case of clauses (i) and (iii) above, for any such
conflict, breach, violation or default that would not, individually or in the aggregate,
have a Material Adverse Effect.
8
(p) No Consents Required. No consent, approval, authorization, order, license,
registration or qualification of or with any court or arbitrator or governmental or
regulatory authority is required for the execution, delivery and performance by the Company
and the Operating Partnership of this Agreement, of each of the Transaction Documents, the
issuance and sale of the Shares and the consummation of the transactions contemplated by
this Agreement and the Transaction Documents, except for the registration of the Shares
under the Securities Act and such consents, approvals, authorizations, orders and
registrations or qualifications as may be required by FINRA, the NYSE and under applicable
state securities laws in connection with the purchase and distribution of the Shares by the
Underwriters.
(q) Legal Proceedings. Except as described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, there are no legal, governmental or regulatory
investigations, actions (excluding pending rulemaking), suits or proceedings pending to
which the Company, the Operating Partnership or any of their subsidiaries is or may be a
party or to which any property of the Company, the Operating Partnership or any of their
subsidiaries (including, without limitation, the Initial Properties) is or may be the
subject that, individually or in the aggregate, if determined adversely to the Company, the
Operating Partnership or any of their subsidiaries, could reasonably be expected to have a
Material Adverse Effect; no such investigations, actions, suits or proceedings are, to the
knowledge of the Company or the Operating Partnership, threatened or contemplated by any
governmental or regulatory authority or threatened by others; and (i) there are no current
or pending legal, governmental or regulatory actions, suits or proceedings that are required
under the Securities Act to be described in the Registration Statement, the Pricing
Disclosure Package or the Prospectus that are not so described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus and (ii) there are no statutes,
regulations or contracts or other documents that are required under the Securities Act to be
filed as exhibits to the Registration Statement or described in the Registration Statement,
the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the
Registration Statement or described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus.
(r) Independent Accountants. KPMG LLP, who have certified certain financial statements
of the Company and its subsidiaries, is an independent registered public accounting firm
with respect to the Company and its subsidiaries within the applicable rules and regulations
adopted by the Commission and the Public Company Accounting Oversight Board (United States)
and as required by the Securities Act.
(s) Title to Real and Personal Property. The Company, the Operating Partnership, any
of their subsidiaries or any joint ventures in which any such entity owns an interest, as
the case may be, has good and insurable fee title or leasehold title to the Initial
Properties and have good title to all other properties owned by them, in each case, free and
clear of all mortgages, pledges, liens, security interests, claims, restrictions or
encumbrances of any kind, except (a) such as are described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, (b) those that do not materially
interfere with the use made and proposed to be made of such property by the Company, the
Operating Partnership, their subsidiaries or any joint venture or (c) those that could not
be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect.
The Initial Properties are not subject to any third party ownership interests other than
the lease agreements with student-tenants entered into in the normal course of business as
described in the Registration Statement, the Pricing Disclosure Package and the Prospectus
and the ground lease agreements and joint venture arrangements described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, and no Person has any
possessory interest in any Initial Property or right to occupy the same except under and
pursuant to (i) the
9
provisions of such leases, (ii) the provisions of such ground leases and joint venture
arrangements, (iii) licenses entered into by the Company, the Operating Partnership or any
of their subsidiaries in the ordinary course of their business or (iv) liens, claims,
encumbrances and restrictions described above.
(t) Title to Intellectual Property. The Company, the Operating Partnership and their
subsidiaries own or possess adequate rights to use all material patents, patent
applications, trademarks, service marks, trade names, trademark registrations, service xxxx
registrations, copyrights, licenses and know-how (including trade secrets and other
unpatented and/or unpatentable proprietary or confidential information, systems or
procedures) necessary for the conduct of their respective businesses as currently conducted
and as proposed to be conducted, and the conduct of their respective businesses will not
conflict in any material respect with any such rights of others. None of the Company, the
Operating Partnership nor any of their subsidiaries have received any notice of any claim of
infringement, misappropriation or conflict with any such rights of others in connection with
its patents, patent rights, licenses, inventions, trademarks, service marks, trade names,
copyrights and know-how, which could reasonably be expected to result in a Material Adverse
Effect.
(u) No Undisclosed Relationships. No relationship, direct or indirect, exists between
or among the Company, the Operating Partnership or any of their subsidiaries, on the one
hand, and the directors, officers, stockholders, customers or suppliers of the Company, the
Operating Partnership or any of their subsidiaries, on the other, that is required by the
Securities Act or the rules and regulations of FINRA to be described in the Registration
Statement and the Prospectus and that is not so described in such documents and in the
Pricing Disclosure Package.
(v) Investment Company Act. Neither the Company nor the Operating Partnership is, and
after giving effect to the offering and sale of the Shares and the application of the
proceeds thereof as described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus neither the Company nor the Operating Partnership will be, required to
register as an “investment company” or an entity “controlled” by an “investment company”
within the meaning of the Investment Company Act of 1940, as amended, and the rules and
regulations of the Commission thereunder (collectively, the “Investment Company Act”).
(w) Taxes. The Company, the Operating Partnership and their subsidiaries have paid all
federal, state, local and foreign taxes and filed all tax returns required to be paid or
filed through the date hereof; and except as otherwise disclosed in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, there is no tax deficiency
that has been, or could reasonably be expected to be, asserted against the Company, the
Operating Partnership or any of their subsidiaries or any of their respective properties or
assets, except those that would not, individually or in the aggregate, have a Material
Adverse Effect.
(x) Licenses and Permits. The Company, the Operating Partnership and their
subsidiaries possess all licenses, certificates, permits and other authorizations issued by,
and have made all declarations and filings with, the appropriate federal, state, local or
foreign governmental or regulatory authorities that are necessary for the ownership or lease
of their respective properties or the conduct of their respective businesses as described in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where
the failure to possess or make the same would not, individually or in the aggregate, have a
Material Adverse Effect; and except as described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, none of the Company, the Operating Partnership nor
any of their subsidiaries has received notice of any revocation or modification of any such
license, certificate, permit or
10
authorization or has any reason to believe that any such license, certificate, permit
or authorization will not be renewed in the ordinary course, except where the failure to
renew would not, individually or in the aggregate, have a Material Adverse Effect.
(y) No Labor Disputes. No labor disturbance by or dispute with employees of the
Company, the Operating Partnership or any of their subsidiaries exists or, to the knowledge
of the Company or the Operating Partnership, is contemplated or threatened, and neither the
Company nor the Operating Partnership is aware of any existing or imminent labor disturbance
by, or dispute with, the employees of any of their or their subsidiaries’ principal
suppliers, contractors or customers, except as would not have a Material Adverse Effect.
(z) Compliance with and Liability under Environmental Laws. The Company, the Operating
Partnership and/or their subsidiaries has received and reviewed environmental reports on
each Initial Property. Except as otherwise set forth in the Registration Statement, the
Pricing Disclosure Package and the Prospectus: (i) the Company is in compliance with, and
none of the Company, the Operating Partnership nor any of their subsidiaries has any
liability with respect to the Initial Properties under, applicable Environmental Laws (as
defined below) except for such non-compliance or liability which would not result in a
Material Adverse Effect; (ii) none of the Company, the Operating Partnership nor any of
their subsidiaries has at any time released (as such term is defined in Section 101 (22) of
CERCLA (as defined below)) or otherwise disposed of or handled, Hazardous Materials (as
defined below) on, to or from any Initial Property, except for such releases, disposals and
handlings as would not be reasonably likely to result in a Material Adverse Effect; (iii)
none of the Company, the Operating Partnership nor any of their subsidiaries knows of any
seepage, leak, discharge, release, emission, spill, or dumping of Hazardous Materials into
waters (including, but not limited to, groundwater and surface water) on, beneath or
adjacent to any Initial Property, other than such matters as would not be reasonably likely
to result in a Material Adverse Effect; (iv) none of the Company, the Operating Partnership
nor any of their subsidiaries has received any written notice of, or has any knowledge of
any occurrence or circumstance which, with notice or passage of time or both, would give
rise to a claim under or pursuant to any Environmental Law by any governmental or
quasi-governmental body or any third party with respect to any Initial Property or arising
out of the conduct of the business of the Company, the Operating Partnership or any of their
subsidiaries at the Initial Properties, except for such claims that would not be reasonably
likely to result in a Material Adverse Effect or that would not be required to be disclosed
in the Registration Statement, the Pricing Disclosure Package or the Prospectus; (v) none of
the Initial Properties is included or, to the knowledge of the Company, proposed for
inclusion on the National Priorities List issued pursuant to CERCLA by the United States
Environmental Protection Agency (the “EPA”) or on any similar list or inventory issued by
any other federal, state or local governmental authority having or claiming jurisdiction
over such properties pursuant to any other Environmental Law, other than such inclusions or
proposed inclusions as would not be reasonably likely to result in a Material Adverse
Effect; and (vi) there are no pending administrative, regulatory or judicial actions, suits,
demands, claims, notices of noncompliance or violation, investigations or proceedings
relating to any applicable Environmental Law against the Company, the Operating Partnership,
any of their subsidiaries or any joint ventures in which any such entity owns an interest or
the Initial Properties. As used herein, “Hazardous Material” shall include, without
limitation, any flammable explosives, radioactive materials, chemicals, pollutants,
contaminants, wastes, hazardous wastes, toxic substances, petroleum or petroleum products,
asbestos-containing materials, mold or any hazardous material as defined by or regulated
under any Environmental Law. As used herein, “Environmental Law” (individually, an
“Environmental Law” and collectively “Environmental Laws”) shall mean any applicable
foreign, federal, state or local law (including statute or common law), ordinance, rule,
regulation, or judicial or administrative order,
11
consent decree or judgment relating to the protection of human health, the environment
(including, without limitation, ambient air, surface water, groundwater, land surface or
subsurface strata) or wildlife, including, without limitation, the Comprehensive
Environmental Response, Compensation and Liability Act of 1980, as amended, 42 U.S.C. Secs.
9601-9675 (“CERCLA”), the Hazardous Materials Transportation Act, as amended, 49 U.S.C.
Secs. 5101-5127, the Solid Waste Disposal Act, as amended, 42 U.S.C. Secs. 6901-6992k, the
Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Secs. 11001-11050, the
Toxic Substances Control Act, 15 U.S.C. Secs. 2601-2692, the Federal Insecticide, Fungicide
and Rodenticide Act, 7 U.S.C. Secs. 136-136y, the Clean Air Act, 42 U.S.C. Secs. 7401-7671q,
the Clean Water Act (Federal Water Pollution Control Act), 33 U.S.C. Secs. 1251-1387, and
the Safe Drinking Water Act, 42 U.S.C. Secs. 300f-300j-26, as any of the above statutes may
be amended from time to time, and the regulations promulgated pursuant to any of the
foregoing.
(aa) Condition of Initial Properties. The Company, the Operating Partnership and/or
their subsidiaries has received and reviewed property condition reports on each Initial
Property. Except as otherwise set forth in the Registration Statement, the Pricing
Disclosure Package and the Prospectus: (i) none of the Initial Properties is in violation of
any applicable building code, zoning ordinance or other law or regulation, except where such
violation of any applicable building code, zoning ordinance or other law or regulation would
not, singly or in the aggregate, have a Material Adverse Effect; (ii) none the Company, the
Operating Partnership nor any of their subsidiaries has received written notice of any
proposed material special assessment or any proposed change in any property tax, zoning or
land use laws or availability of water affecting any Initial Property that would, singly or
in the aggregate, have a Material Adverse Effect; (iii) there does not exist any violation
of any declaration of covenants, conditions and restrictions with respect to any Initial
Property which would, singly or in the aggregate, have a Material Adverse Effect, or any
state of facts or circumstances or condition or event which could, with the giving of notice
or passage of time, or both, constitute such a violation; and (iv) the developments or
improvements comprising any portion of each Initial Property (the “Developments and
Improvements”) are free of any and all physical, mechanical, structural, design or
construction defects that would, singly or in the aggregate, have a Material Adverse Effect
and the mechanical, electrical and utility systems servicing the Developments and
Improvements (including, without limitation, all water, electric, sewer, plumbing, heating,
ventilation, gas and air conditioning) are in good condition and proper working order,
reasonable wear and tear and need for routine repair and maintenance excepted, and are free
of defects, except for such failures and defects that would not, singly or in the aggregate,
have a Material Adverse Effect.
(bb) Access and Utilities. Each of the Initial Properties has rights of access to
public ways and is served by water, sewer, sanitary sewer and storm drain facilities
adequate to service such Initial Property for its use as described in the Registration
Statement, Pricing Disclosure Package and the Prospectus. All public utilities necessary to
the use and enjoyment of each of the Initial Properties in the manner described in the
Prospectus is located either in the public right-of-way abutting such Initial Property
(which are connected so as to serve such Initial Property without passing over other
property) or in recorded easements serving such Initial Property, subject to such exceptions
which, singly or in the aggregate, would not have a Material Adverse Effect. All roads
necessary for the use of each of the Initial Properties as described in the Registration
Statement, Pricing Disclosure Package and the Prospectus have been completed and dedicated
to public use and accepted by all applicable governmental authorities.
(cc) No Condemnation. No condemnation or other proceeding has been commenced that has
not been completed, and, to the Company’s or the Operating Partnership’s knowledge, no such
proceeding is threatened, with respect to all or any portion of the Initial Properties or
for the
12
relocation away from any Initial Property of any roadway providing access to the
Initial Properties or any portion thereof.
(dd) Compliance with ERISA. (i) Each employee benefit plan, within the meaning of
Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”),
for which the Company or any member of its “Controlled Group” (defined as any organization
which is a member of a controlled group of corporations within the meaning of Section 414 of
the Internal Revenue Code of 1986, as amended (the “Code”)) would have any liability (each,
a “Plan”) has been maintained in compliance with its terms and the requirements of any
applicable statutes, orders, rules and regulations, including but not limited to ERISA and
the Code, except for noncompliance that could not reasonably be expected to result in
material liability to the Company, the Operating Partnership or their subsidiaries; (ii) no
prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the
Code, has occurred with respect to any Plan excluding transactions effected pursuant to a
statutory or administrative exemption that could reasonably be expected to result in a
material liability to the Company, the Operating Partnership or their subsidiaries; (iii)
for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302
of ERISA, the minimum funding standard of Section 412 of the Code or Section 302 of ERISA,
as applicable, has been satisfied (without taking into account any waiver thereof or
extension of any amortization period) and is reasonably expected to be satisfied in the
future (without taking into account any waiver thereof or extension of any amortization
period); (iv) the fair market value of the assets of each Plan exceeds the present value of
all benefits accrued under such Plan (determined based on those assumptions used to fund
such Plan); (v) no “reportable event” (within the meaning of Section 4043(c) of ERISA) has
occurred or is reasonably expected to occur that either has resulted, or could reasonably be
expected to result, in material liability to the Company, the Operating Partnership or their
subsidiaries; (vi) none of the Company, the Operating Partnership nor any member of the
Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV
of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty
Corporation (“PBGC”), in the ordinary course and without default) in respect of a Plan
(including a “multiemployer plan,” within the meaning of Section 4001(a)(3) of ERISA); and
(vii) there is no pending audit or investigation by the Internal Revenue Service, the U.S.
Department of Labor, the PBGC or any other governmental agency or any foreign regulatory
agency with respect to any Plan that could reasonably be expected to result in material
liability to the Company, the Operating Partnership or their subsidiaries. None of the
following events has occurred or is reasonably likely to occur: (x) a material increase in
the aggregate amount of contributions required to be made to all Plans by the Company, the
Operating Partnership or their subsidiaries in the current fiscal year of the Company, the
Operating Partnership or their subsidiaries compared to the amount of such contributions
made in the most recently completed fiscal year; or (y) a material increase in the
Company’s, the Operating Partnership’s and their subsidiaries’ “accumulated post-retirement
benefit obligations” (within the meaning of Statement of Financial Accounting Standards 106)
compared to the amount of such obligations in the most recently completed fiscal year.
Furthermore, the assets of the Company, the Operating Partnership or their subsidiaries are
not deemed to constitute “plan assets” for purposes of ERISA or the regulations of United
States Department of Labor under ERISA.
(ee) Disclosure Controls. The Company, the Operating Partnership and their
subsidiaries have taken all necessary actions to ensure that, upon effectiveness of the
Registration Statement, the Company, the Operating Partnership and their subsidiaries will
maintain an effective system of “disclosure controls and procedures” (as defined in Rule
13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that
complies with the requirements of the Exchange Act and the rules and regulations of the
Commission thereunder,
13
and that has been designed to ensure that information required to be disclosed by the
Company in reports that it files or submits under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the Commission’s rules and
forms, including controls and procedures designed to ensure that such information is
accumulated and communicated to the Company’s management as appropriate to allow timely
decisions regarding required disclosure. The Company, the Operating Partnership and their
subsidiaries will evaluate the effectiveness of their disclosure controls and procedures as
required by Rule 13a-15 of the Exchange Act.
(ff) Accounting Controls. The Company, the Operating Partnership and their
subsidiaries have taken all necessary actions to ensure that, upon effectiveness of the
Registration Statement, the Company, the Operating Partnership and their subsidiaries will
maintain systems of “internal control over financial reporting” (as defined in Rule
13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and
have been designed by, or under the supervision of, their respective principal executive and
principal financial officers, or persons performing similar functions, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles, including, but not limited to, internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance with
management’s general or specific authorizations; (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with generally accepted
accounting principles and to maintain asset accountability; (iii) access to assets is
permitted only in accordance with management’s general or specific authorization; and (iv)
the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. Except as
disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
there are no identified deficiencies in such internal controls. The Company’s auditors and
the Audit Committee of the Board of Directors of the Company have been advised of: (i) all
identified deficiencies and material weaknesses in the design or operation of internal
controls over financial reporting which have adversely affected or are reasonably likely to
adversely affect the Company’s ability to record, process, summarize and report financial
information; and (ii) any fraud, whether or not material, that involves management or other
employees who have a significant role in the Company’s internal controls over financial
reporting.
(gg) Insurance. The Company, the Operating Partnership and their subsidiaries have
insurance covering their respective properties, operations, personnel and businesses,
including business interruption insurance, which insurance is in amounts and insures against
such losses and risks as are adequate to protect the Company, the Operating Partnership and
their subsidiaries and their respective businesses; and none of the Company, the Operating
Partnership nor any of their subsidiaries has (i) received notice from any insurer or agent
of such insurer that capital improvements or other expenditures are required or necessary to
be made in order to continue such insurance or (ii) any reason to believe that it will not
be able to renew its existing insurance coverage as and when such coverage expires or to
obtain similar coverage at reasonable cost from similar insurers as may be necessary to
continue its business.
(hh) Title Insurance. The Company, the Operating Partnership and/or their subsidiaries
carries or is entitled to the benefits of title insurance on the fee interests and/or
leasehold interests (in the case of a ground lease interest) with respect to each Initial
Property with financially sound and reputable insurers, in an amount not less than such
entity’s cost for the real property comprising such Initial Property, insuring that such
party is vested with good and insurable title to each such Initial Property.
14
(ii) No Unlawful Payments. None of the Company, the Operating Partnership nor any of
their subsidiaries nor, to the knowledge of the Company or the Operating Partnership, any
director, officer, agent, employee or other person associated with or acting on behalf of
the Company, the Operating Partnership or any of their subsidiaries has: (i) used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense
relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or
is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended;
or (iv) made any bribe, rebate, payoff, influence payment, kickback or other unlawful
payment.
(jj) Compliance with Money Laundering Laws. The operations of the Company, the
Operating Partnership and their subsidiaries are and have been conducted at all times in
compliance with applicable financial recordkeeping and reporting requirements of the
Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering
statutes of all jurisdictions, the rules and regulations thereunder and any related or
similar rules, regulations or guidelines, issued, administered or enforced by any
governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or
proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company, the Operating Partnership or any of their subsidiaries
with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or
the Operating Partnership, threatened.
(kk) Compliance with OFAC. None of the Company, the Operating Partnership nor any of
their subsidiaries nor, to the knowledge of the Company or the Operating Partnership, any
director, officer, agent, employee or affiliate of the Company, the Operating Partnership or
any of their subsidiaries is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”); and the
Company or the Operating Partnership will not, directly or indirectly, use the proceeds of
the offering of the Shares hereunder, or lend, contribute or otherwise make available such
proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose
of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.
(ll) No Restrictions on Subsidiaries. No subsidiary of the Company (including the
Operating Partnership) is currently prohibited, directly or indirectly, under any agreement
or other instrument to which it is a party or is subject, from paying any dividends to the
Company, from making any other distribution on such subsidiary’s capital stock, from
repaying to the Company any loans or advances to such subsidiary from the Company or from
transferring any of such subsidiary’s properties or assets to the Company or any other
subsidiary of the Company.
(mm) No Broker’s Fees. None of the Company, the Operating Partnership nor any of their
subsidiaries is a party to any contract, agreement or understanding with any person (other
than this Agreement) that would give rise to a valid claim against the Company, the
Operating Partnership or any of their subsidiaries or any Underwriter for a brokerage
commission, finder’s fee or like payment in connection with the offering and sale of the
Shares.
(nn) No Registration Rights. Except as disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, no person has the right to require the
Company, the Operating Partnership or any of their subsidiaries to register any securities
for sale under the Securities Act by reason of the filing of the Registration Statement with
the Commission or the issuance and sale of the Shares.
15
(oo) No Stabilization. Neither the Company nor the Operating Partnership has taken,
directly or indirectly, any action designed to or that could reasonably be expected to cause
or result in any stabilization or manipulation of the price of the Shares.
(pp) Margin Rules. The application of the proceeds received by the Company from the
issuance, sale and delivery of the Shares as described in the Registration Statement, the
Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the
Board of Governors of the Federal Reserve System or any other regulation of such Board of
Governors.
(qq) Forward-Looking Statements. No forward-looking statement (within the meaning of
Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in the
Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or
reaffirmed without a reasonable basis or has been disclosed other than in good faith.
(rr) Statistical and Market Data. Nothing has come to the attention of the Company
that has caused the Company to believe that the statistical and market-related data included
in the Registration Statement, the Pricing Disclosure Package and the Prospectus is not
based on or derived from sources that are reliable and accurate in all material respects and
the Company has obtained, if required, the written consent to the use of such data from such
sources requiring consent.
(ss) Xxxxxxxx-Xxxxx Act. The Company has taken all necessary actions to ensure that,
upon effectiveness of the Registration Statement, it will be, and any of the Company’s
directors or officers, in their capacities as such will be, in compliance with all
applicable provisions of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations
promulgated in connection therewith, including Section 402 related to loans and Sections 302
and 906 related to certifications.
(tt) Status under the Securities Act. At the time of filing the Registration Statement
and any post-effective amendment thereto, at the earliest time thereafter that the Company
or any offering participant made a bona fide offer (within the meaning of Rule 164(h)(2)
under the Securities Act) of the Shares and at the date hereof, the Company was not and is
not an “ineligible issuer,” as defined in Rule 405 under the Securities Act. The Company
has paid the registration fee for this offering as calculated pursuant to Rule 457 under the
Securities Act.
(uu) Real Estate Investment Trust. As of the Closing Date and after giving effect to
the issuance and sale of the Shares and the application of the net proceeds therefrom as
described in the Registration Statement, Pricing Disclosure Package and the Prospectus, the
Company will be organized and will operate in a manner so as to qualify as a “real estate
investment trust” (a “REIT”) under Sections 856 to 860 of the Code, and the rules and
regulations thereunder, and the Company will elect to be taxed as a REIT under the Code
effective for its taxable year ending December 31, 2010. All statements regarding the
Company’s qualification and taxation as a REIT and descriptions of the Company’s
organization and proposed method of operation set forth in the Registration Statement,
Pricing Disclosure Package and the Prospectus are true, complete and correct in all material
respects.
(vv) Partnership Agreement. The Amended and Restated Limited Partnership Agreement of
the Operating Partnership (the “Partnership Agreement”), has been duly and validly
authorized by Campus Crest Communities GP, LLC, a wholly-owned subsidiary of the Company,
acting in its capacity as sole general partner of the Operating Partnership, and at the
Closing Date will be duly executed and delivered by Campus Crest Communities GP, LLC, as
16
general partner, and will be a valid and binding agreement, enforceable in accordance
with its terms, except to the extent that enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally
and by general equitable principles.
(ww) Operating Partnership. The Operating Partnership will be classified as a
partnership for purposes of the Code and will not be treated as a publicly traded
partnership, association or corporation.
(xx) Directed Share Program. The Registration Statement, the Pricing Disclosure Package
and the Prospectus comply, and any further amendments or supplements thereto will comply, in
all material respects, with any applicable laws or regulations of each jurisdiction in which
the Pricing Disclosure Package or the Prospectus, as amended or supplemented, if applicable,
is distributed in connection with the Directed Share Program, and no material authorization,
approval, consent, license, order, registration or qualification of or with any court or
governmental or regulatory authority, other than such as have been obtained or will be
obtained or completed by the Closing Date, is necessary under the securities laws and
regulations of any such jurisdiction. Neither the Company nor the Operating Partnership has
offered, or caused the Underwriters to offer, Shares to any person pursuant to the Directed
Share Program with the specific intent to unlawfully influence (i) a customer or supplier of
the Company to alter the customer’s or supplier’s level or type of business with the Company
or (ii) a trade journalist or publication to write or publish favorable information about
the Company or its products.
4. Further Agreements of the Company and the Operating Partnership. Each of the
Company and the Operating Partnership, jointly and severally, covenants and agrees with each
Underwriter that:
(a) Required Filings. The Company will file the Prospectus with the Commission within
the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities
Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under
the Securities Act; and will furnish copies of the Prospectus and each Issuer Free Writing
Prospectus (to the extent not previously delivered) to the Underwriters in New York City
prior to 10:00 A.M., New York City time, on the business day next succeeding the date of
this Agreement in such quantities as the Representatives may reasonably request.
(b) Delivery of Copies. The Company will deliver, without charge, (i) to the
Representatives, two signed copies of the Registration Statement as originally filed and
each amendment thereto, in each case including all exhibits and consents filed therewith;
and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as
originally filed and each amendment thereto (without exhibits) and (B) during the Prospectus
Delivery Period (as defined below), as many copies of the Prospectus (including all
amendments and supplements thereto and each Issuer Free Writing Prospectus) as the
Representatives may reasonably request. As used herein, the term “Prospectus Delivery
Period” means such period of time after the first date of the public offering of the Shares
as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is
required by law to be delivered (or required to be delivered but for Rule 172 under the
Securities Act) in connection with sales of the Shares by any Underwriter or dealer.
(c) Amendments or Supplements, Issuer Free Writing Prospectuses. Before preparing,
using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus,
and before filing any amendment or supplement to the Registration Statement or the
Prospectus, the Company will furnish to the Representatives and counsel for the Underwriters
a copy of the
17
proposed Issuer Free Writing Prospectus, amendment or supplement for review and will
not prepare, use, authorize, approve, refer to or file any such Issuer Free Writing
Prospectus or file any such proposed amendment or supplement to which the Representatives
object.
(d) Notice to the Representatives. The Company will advise the Representatives
promptly, and confirm such advice in writing: (i) when the Registration Statement has become
effective; (ii) when any amendment to the Registration Statement has been filed or becomes
effective; (iii) when any supplement to the Prospectus or any Issuer Free Writing Prospectus
or any amendment to the Prospectus has been filed; (iv) of any request by the Commission for
any amendment to the Registration Statement or any amendment or supplement to the Prospectus
or the receipt of any comments from the Commission relating to the Registration Statement or
any other request by the Commission for any additional information; (v) of the issuance by
the Commission of any order suspending the effectiveness of the Registration Statement or
preventing or suspending the use of any Preliminary Prospectus, any of the Pricing
Disclosure Package or the Prospectus or the initiation or threatening of any proceeding for
that purpose or pursuant to Section 8A of the Securities Act; (vi) of the occurrence of any
event within the Prospectus Delivery Period as a result of which the Prospectus, the Pricing
Disclosure Package or any Issuer Free Writing Prospectus as then amended or supplemented
would include any untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances
existing when the Prospectus, the Pricing Disclosure Package or any such Issuer Free Writing
Prospectus is delivered to a purchaser, not misleading; and (vii) of the receipt by the
Company of any notice with respect to any suspension of the qualification of the Shares for
offer and sale in any jurisdiction or the initiation or threatening of any proceeding for
such purpose; and the Company will use its best efforts to prevent the issuance of any such
order suspending the effectiveness of the Registration Statement, preventing or suspending
the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the
Prospectus or suspending any such qualification of the Shares and, if any such order is
issued, will obtain as soon as possible the withdrawal thereof.
(e) Ongoing Compliance. (1) If during the Prospectus Delivery Period (i) any event
shall occur or condition shall exist as a result of which the Prospectus as then amended or
supplemented would include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the
circumstances existing when the Prospectus is delivered to a purchaser, not misleading or
(ii) it is necessary to amend or supplement the Prospectus to comply with law, the Company
will promptly notify the Underwriters thereof and forthwith prepare and, subject to
paragraph (c) above, file with the Commission and furnish to the Underwriters and to such
dealers as the Representatives may designate such amendments or supplements to the
Prospectus as may be necessary so that the statements in the Prospectus as so amended or
supplemented will not, in the light of the circumstances existing when the Prospectus is
delivered to a purchaser, be misleading or so that the Prospectus will comply with law and
(2) if at any time prior to the Closing Date (i) any event shall occur or condition shall
exist as a result of which the Pricing Disclosure Package as then amended or supplemented
would include any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of the circumstances
existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or
(ii) it is necessary to amend or supplement the Pricing Disclosure Package to comply with
law, the Company will promptly notify the Underwriters thereof and forthwith prepare and,
subject to paragraph (c) above, file with the Commission (to the extent required) and
furnish to the Underwriters and to such dealers as the Representatives may designate such
amendments or supplements to the Pricing Disclosure Package as may be necessary so that the
statements in the Pricing Disclosure Package as so amended or supplemented will not, in the
light
18
of the circumstances existing when the Pricing Disclosure Package is delivered to a
purchaser, be misleading or so that the Pricing Disclosure Package will comply with law.
(f) Blue Sky Compliance. The Company will qualify the Shares for offer and sale under
the securities or Blue Sky laws of such jurisdictions as the Representatives shall
reasonably request and will continue such qualifications in effect so long as required for
distribution of the Shares; provided that the Company shall not be required to (i)
qualify as a foreign corporation or other entity or as a dealer in securities in any such
jurisdiction where it would not otherwise be required to so qualify, (ii) file any general
consent to service of process in any such jurisdiction or (iii) subject itself to taxation
in any such jurisdiction if it is not otherwise so subject.
(g) Earning Statement. The Company will make generally available to its security
holders and the Representatives as soon as practicable an earnings statement that satisfies
the provisions of Section 11(a) of the Securities Act and Rule 158 under the Securities Act
covering a period of at least twelve months beginning with the first fiscal quarter of the
Company occurring after the “effective date” (as defined in Rule 158) of the Registration
Statement.
(h) Clear Market. During a period of one year from the date of the Prospectus, the
Company will not, directly or indirectly (i) offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant for the sale of, or lend or otherwise transfer or dispose of any
shares of Stock or any securities convertible into or exercisable or exchangeable for or
repayable with shares of Stock, whether owned as of the date hereof or hereafter acquired or
with respect to which the Company has or hereafter acquires the power of disposition, or
file, or cause to be filed, any registration statement under the Securities Act with respect
to any of the foregoing (collectively, the “Lock-Up Securities”) or (ii) enter into any swap
or any other agreement or any transaction that transfers, in whole or in part, directly or
indirectly, the economic consequence of ownership of the Lock-Up Securities, whether any
such swap, agreement or transaction is to be settled by delivery of Stock or other
securities, in cash or otherwise, without the prior written consent of the Representatives,
other than the Shares to be sold hereunder and any shares of Stock of the Company issued
under the Equity Incentive Plan as described in the Registration Statement, Pricing
Disclosure Package and Prospectus. Notwithstanding the foregoing, if (1) during the last 17
days of the one-year restricted period, the Company issues an earnings release or material
news or a material event relating to the Company occurs; or (2) prior to the expiration of
the one-year restricted period, the Company announces that it will release earnings results
or becomes aware that material news or a material event will occur during the 16-day period
beginning on the last day of the one-year period, the restrictions imposed by this Agreement
shall continue to apply until the expiration of the 18-day period beginning on the issuance
of the earnings release or the occurrence of the material news or material event.
(i) Use of Proceeds. The Company will apply the net proceeds from the sale of the
Shares as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus under the heading “Use of Proceeds.”
(j) No Stabilization. The Company will not take, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result in any stabilization or
manipulation of the price of the Stock.
(k) Exchange Listing. The Company will use its best efforts to list, subject to notice
of issuance, the Shares on the New York Stock Exchange (the “Exchange”).
19
(l) Reports. So long as the Shares are outstanding, the Company will furnish to the
Representatives, as soon as they are available, copies of all reports or other
communications (financial or other) furnished to holders of the Shares, and copies of any
reports and financial statements furnished to or filed with the Commission or any national
securities exchange or automatic quotation system; provided the Company will be
deemed to have furnished such reports and financial statements to the Representatives to the
extent they are filed on the Commission’s Electronic Data Gathering, Analysis, and Retrieval
system or any successor system.
(m) Record Retention. The Company will, pursuant to reasonable procedures developed in
good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the
Commission in accordance with Rule 433 under the Securities Act.
(n) Filings. The Company will file with the Commission such reports as may be required
by Rule 463 under the Securities Act.
5. Certain Agreements of the Underwriters. Each Underwriter hereby represents and
agrees that:
(a) It has not used, authorized use of, referred to or participated in the planning for
use of, and will not use, authorize use of, refer to or participate in the planning for use
of, any “free writing prospectus,” as defined in Rule 405 under the Securities Act (which
term includes use of any written information furnished to the Commission by the Company and
not incorporated by reference into the Registration Statement and any press release issued
by the Company) other than (i) a free writing prospectus that contains no “issuer
information” (as defined in Rule 433(h)(2) under the Securities Act) that was not included
(including through incorporation by reference) in the Preliminary Prospectus or a previously
filed Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on
Annex B or prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic
road show), or (iii) any free writing prospectus prepared by such underwriter and approved
by the Company in advance in writing (each such free writing prospectus referred to in
clauses (i) or (iii), an “Underwriter Free Writing Prospectus”).
(b) It has not and will not, without the prior written consent of the Company, use any
free writing prospectus that contains the final terms of the Shares unless such terms have
previously been included in a free writing prospectus filed with the Commission.
(c) It is not subject to any pending proceeding under Section 8A of the Securities Act
with respect to the offering (and will promptly notify the Company if any such proceeding
against it is initiated during the Prospectus Delivery Period).
6. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to
purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing
Date, as the case may be, as provided herein is subject to the performance by the Company of its
covenants and other obligations hereunder and to the following additional conditions:
(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of
the Registration Statement shall be in effect, and no proceeding for such purpose pursuant
to Section 8A under the Securities Act shall be pending before or threatened by the
Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely
filed with the Commission under the Securities Act (in the case of an Issuer Free Writing
Prospectus, to the
20
extent required by Rule 433 under the Securities Act) and in accordance with Section
4(a) hereof; and all requests by the Commission for additional information shall have been
complied with to the reasonable satisfaction of the Representatives.
(b) Representations and Warranties. The representations and warranties of the Company
and the Operating Partnership contained herein shall be true and correct on the date hereof
and on and as of the Closing Date or the Additional Closing Date, as the case may be; and
the statements of the Company, the Operating Partnership and their respective officers made
in any certificates delivered pursuant to this Agreement shall be true and correct on and as
of the Closing Date or the Additional Closing Date, as the case may be.
(c) No Material Adverse Change. No event or condition of a type described in Section
3(f) hereof shall have occurred or shall exist, which event or condition is not described in
the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the
Prospectus (excluding any amendment or supplement thereto) and the effect of which, in the
judgment of the Representatives makes it impracticable or inadvisable to proceed with the
offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date,
as the case may be, on the terms and in the manner contemplated by this Agreement, the
Pricing Disclosure Package and the Prospectus.
(d) Company Officers’ Certificate. The Representatives shall have received on and as
of the Closing Date or the Additional Closing Date, as the case may be, a certificate of the
chief executive officer and chief financial officer or chief accounting officer of the
Company (i) confirming that such officers have carefully reviewed the Registration
Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such
officers, the representations set forth in Sections 3(b) and 3(d) hereof are true and
correct, (ii) confirming that the other representations and warranties of the Company in
this Agreement are true and correct and that the Company has complied with all agreements
and satisfied all conditions on its part to be performed or satisfied hereunder at or prior
to the Closing Date or the Additional Closing Date, as the case may be, and (iii) to the
effect set forth in paragraphs (a) and (c) above.
(e) Company’s Chief Financial Officer’s Certificate. The Representatives shall have
received on and as of the Closing Date or the Additional Closing Date, as the case may be, a
certificate of the chief financial officer of the Company in a form reasonably satisfactory
to the Representatives.
(f) Operating Partnership Officers’ Certificate. The Representatives shall have
received on and as of the Closing Date or the Additional Closing Date, as the case may be, a
certificate of the chief executive officer and chief financial officer or chief accounting
officer of Campus Crest Communities GP, LLC, the general partner of the Operating
Partnership, confirming that the representations and warranties of the Operating Partnership
in this Agreement are true and correct and that the Operating Partnership has complied with
all agreements and satisfied all conditions on its part to be performed or satisfied
hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may
be.
(g) Comfort Letters. On the date of this Agreement and on the Closing Date or the
Additional Closing Date, as the case may be, KPMG LLP shall have furnished to the
Representatives, at the request of the Company, letters, dated the respective dates of
delivery thereof and addressed to the Underwriters, in form and substance reasonably
satisfactory to the Representatives, containing statements and information of the type
customarily included in accountants’ “comfort letters” to underwriters with respect to the
financial statements and certain
21
financial information contained in the Registration Statement, the Pricing Disclosure
Package and the Prospectus; provided, that the letter delivered on the Closing Date or the
Additional Closing Date, as the case may be, shall use a “cut-off” date no more than three
business days prior to such Closing Date or such Additional Closing Date, as the case may
be.
(h) Opinion and 10b-5 Statement of Counsel for the Company and the Operating
Partnership. Xxxxxxx Xxxxx Xxxxx Xxxxxxxx LLP and Xxxx Xxxxx LLP, counsel for the Company
and the Operating Partnership, shall have furnished to the Representatives, at the request
of the Company, their respective written opinion and 10b-5 statement, dated the Closing Date
or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in
form and substance reasonably satisfactory to the Representatives, to the effect set forth
in Annex A-1 and Annex A-2 hereto, respectively.
(i) Opinion and 10b-5 Statement of Counsel for the Underwriters. The Representatives
shall have received on and as of the Closing Date or the Additional Closing Date, as the
case may be, an opinion and 10b-5 statement of Sidley Austin llp, counsel for the
Underwriters, with respect to such matters as the Representatives may reasonably request,
and such counsel shall have received such documents and information as they may reasonably
request to enable them to pass upon such matters. In giving such opinion such counsel may
rely, as to all matters governed by the laws of jurisdictions other than the law of the
State of New York and the federal law of the United States, upon the opinion and 10b-5
statement of Xxxx Xxxxx LLP delivered pursuant to Section 6(g) as to matters
arising under Maryland law, or upon the opinions and 10b-5 statements of counsel
satisfactory to the Representatives.
(j) No Legal Impediment to Issuance. No action shall have been taken and no statute,
rule, regulation or order shall have been enacted, adopted or issued by any federal, state
or foreign governmental or regulatory authority that would, as of the Closing Date or the
Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares; and
no injunction or order of any federal, state or foreign court shall have been issued that
would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent
the issuance or sale of the Shares.
(k) Good Standing. The Representatives shall have received on and as of the Closing
Date or the Additional Closing Date, as the case may be, satisfactory evidence of the good
standing of the Company, the Operating Partnership and their subsidiaries in their
respective jurisdictions of organization and their good standing as foreign entities in such
other jurisdictions as the Representatives may reasonably request, in each case in writing
or any standard form of telecommunication from the appropriate governmental authorities of
such jurisdictions.
(l) Exchange Listing. The Shares to be delivered on the Closing Date or Additional
Closing Date, as the case may be, shall have been approved for listing on the New York Stock
Exchange, subject to official notice of issuance.
(m) Lock-up Agreements. The “lock-up” agreements, each substantially in the form of
Exhibit A hereto, between you and the parties set forth on Exhibit B hereto relating to
sales and certain other dispositions of shares of Stock or certain other securities,
delivered to you on or before the date hereof, shall be full force and effect on the Closing
Date or Additional Closing Date, as the case may be.
(n) No Objection. FINRA shall have confirmed that it has not raised any objection with
respect to the fairness and reasonableness of the underwriting terms and arrangements.
22
(o) Transaction Documents. All of the Transaction Documents shall have been executed
and delivered contemporaneously with or prior to the sale of the Shares
(p) Additional Documents. On or prior to the Closing Date or the Additional Closing
Date, as the case may be, the Company shall have furnished to the Representatives such
further certificates and documents as the Representatives may reasonably request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
7. Indemnification and Contribution.
(a) Indemnification of the Underwriters. The Company and the Operating Partnership,
jointly and severally, agree to indemnify and hold harmless each Underwriter, its
affiliates, agents, joint ventures, directors and officers and each person, if any, who
controls such Underwriter within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities
(including, without limitation, legal fees and other expenses incurred in connection with
any suit, action or proceeding or any claim asserted, as such fees and expenses are
incurred), joint or several, that arise out of, or are based upon, (i) any untrue statement
or alleged untrue statement of a material fact contained in the Registration Statement or
caused by any omission or alleged omission to state therein a material fact required to be
stated therein or necessary in order to make the statements therein, not misleading, (ii) or
any untrue statement or alleged untrue statement of a material fact contained in the
Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus, any
“issuer information” filed or required to be filed pursuant to Rule 433(d) under the
Securities Act or any Pricing Disclosure Package (including any Pricing Disclosure Package
that has subsequently been amended), or caused by any omission or alleged omission to state
therein a material fact necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading, in each case except insofar as
such losses, claims, damages or liabilities arise out of, or are based upon, any untrue
statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to any Underwriter furnished to the Company in
writing by such Underwriter through the Representatives expressly for use therein, it being
understood and agreed that the only such information furnished by any Underwriter consists
of the information described as such in paragraph (b) below.
(b) Indemnification of the Company and the Operating Partnership. Each Underwriter
agrees, severally and not jointly, to indemnify and hold harmless the Company, the Operating
Partnership, the Company’s directors and officers who signed the Registration Statement and
each person, if any, who controls either the Company or the Operating Partnership within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same
extent as the indemnity set forth in paragraph (a) above, but only with respect to any
losses, claims, damages or liabilities that arise out of, or are based upon, any untrue
statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to such Underwriter furnished to the Company in
writing by such Underwriter through the Representatives expressly for use in the
Registration Statement, the Prospectus (or any amendment or supplement thereto), any Issuer
Free Writing Prospectus or any Pricing Disclosure Package, it being understood and agreed
upon that the only such information furnished by any Underwriter consists of the following
information in the Prospectus furnished
23
on behalf of each Underwriter: the concession and reallowance figures appearing in the
fifth paragraph under the caption “Underwriting.”
(c) Notice and Procedures. If any suit, action, proceeding (including any governmental
or regulatory investigation), claim or demand shall be brought or asserted against any
person in respect of which indemnification may be sought pursuant to either paragraph (a) or
(b) above, such person (the “Indemnified Person”) shall promptly notify the person against
whom such indemnification may be sought (the “Indemnifying Person”) in writing;
provided that the failure to notify the Indemnifying Person shall not relieve it
from any liability that it may have under paragraph (a) or (b) above except to the extent
that it has been materially prejudiced (through the forfeiture of substantive rights or
defenses) by such failure; and provided, further, that the failure to notify
the Indemnifying Person shall not relieve it from any liability that it may have to an
Indemnified Person otherwise than under paragraph (a) or (b) above. If any such proceeding
shall be brought or asserted against an Indemnified Person and it shall have notified the
Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the
Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified
Person in such proceeding and shall pay the fees and expenses of such counsel related to
such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the
right to retain its own counsel, but the fees and expenses of such counsel shall be at the
expense of such Indemnified Person unless: (i) the Indemnifying Person and the Indemnified
Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed
within a reasonable time to retain counsel reasonably satisfactory to the Indemnified
Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal
defenses available to it that are different from or in addition to those available to the
Indemnifying Person; or (iv) the named parties in any such proceeding (including any
impleaded parties) include both the Indemnifying Person and the Indemnified Person and
representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interest between them. It is understood and agreed that the
Indemnifying Person shall not, in connection with any proceeding or related proceedings in
the same jurisdiction, be liable for the fees and expenses of more than one separate firm
(in addition to any local counsel) for all Indemnified Persons, and that all such fees and
expenses shall be paid or reimbursed as they are incurred upon receipt from the Indemnified
Persons of a written request for payment thereof accompanied by a written statement with
reasonable supporting detail of such fees and expenses. Any such separate firm for any
Underwriter, its affiliates, directors and officers and any control persons of such
Underwriter shall be designated in writing by the Representatives and any such separate firm
for the Company, the Operating Partnership, the Company’s directors and officers who signed
the Registration Statement and any control persons of the Company or the Operating
Partnership shall be designated in writing by the Company. The Indemnifying Person shall
not be liable for any settlement of any proceeding effected without its written consent, but
if settled with such consent or if there be a final judgment for the plaintiff, the
Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or
liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence,
if at any time an Indemnified Person shall have requested that an Indemnifying Person
reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this
paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding
effected without its written consent if (i) such settlement is entered into more than 30
days after receipt by the Indemnifying Person of such request, (ii) the Indemnifying Person
shall not have reimbursed the Indemnified Person in accordance with such request prior to
the date of such settlement and (iii) arising out of, related to, or in connection with the
Directed Share Program, other than losses, claims, damages or liabilities (or expenses
relating thereto) that are finally judicially determined to have resulted from the willful
misconduct or gross negligence of an Underwriter. No
24
Indemnifying Person shall, without the written consent of the Indemnified Person,
effect any settlement of any pending or threatened proceeding in respect of which any
Indemnified Person is or could have been a party and indemnification could have been sought
hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional
release of such Indemnified Person, in form and substance reasonably satisfactory to such
Indemnified Person, from all liability on claims that are the subject matter of such
proceeding and (y) does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of any Indemnified Person.
(d) Contribution. If the indemnification provided for in paragraphs (a) and (b) above
is unavailable to an Indemnified Person or insufficient in respect of any losses, claims,
damages or liabilities referred to therein, then each Indemnifying Person under such
paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to
the amount paid or payable by such Indemnified Person as a result of such losses, claims,
damages or liabilities (i) in such proportion as is appropriate to reflect the relative
benefits received by the Company and the Operating Partnership, on the one hand, and the
Underwriters on the other, from the offering of the Shares or (ii) if the allocation
provided by clause (i) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i) but also the
relative fault of the Company and the Operating Partnership, on the one hand, and the
Underwriters on the other, in connection with the statements or omissions that resulted in
such losses, claims, damages or liabilities, as well as any other relevant equitable
considerations. The relative benefits received by the Company and the Operating
Partnership, on the one hand, and the Underwriters on the other, shall be deemed to be in
the same respective proportions as the net proceeds (before deducting expenses) received by
the Company from the sale of the Shares and the total underwriting discounts and commissions
received by the Underwriters in connection therewith, in each case as set forth in the table
on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The
relative fault of the Company and the Operating Partnership, on the one hand, and the
Underwriters on the other, shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Company, the
Operating Partnership or by the Underwriters and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission.
(e) Sale of Directed Shares. In connection with the offer and sale of Directed Shares,
the Company and the Operating Partnership, jointly and severally, agree to indemnify and
hold harmless each Underwriter, its affiliates, agents, joint ventures, directors and
officers and each person, if any, who controls such Underwriter within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and
all losses, claims, damages and liabilities (including, without limitation, legal fees and
other expenses incurred in connection with any suit, action or proceeding or any claim
asserted, as such fees and expenses are incurred), joint or several, that arise out of, or
are based upon, (i) the violation of any applicable laws or regulations of any foreign
jurisdictions where Directed Shares have been offered or (ii) the failure of any purchaser
of Directed Shares, who has agreed to purchase Directed Shares, to pay for and accept
delivery of the Directed Shares. Under no circumstances will any Underwriter be liable to
the Company, the Operating Partnership or to any purchaser of Directed Shares for any action
taken or omitted to be taken in connection with the Directed Shares or any transaction
effected with any purchaser of Directed Shares, except to the extent found in a final
judgment by a court of competent jurisdiction (not subject to further appeal) to have
resulted primarily and directly from the gross negligence or willful misconduct of such
Underwriter.
25
(f) Limitation on Liability. The Company, the Operating Partnership and the
Underwriters agree that it would not be just and equitable if contribution pursuant to this
Section 7 were determined by pro rata allocation (even if the Underwriters
were treated as one entity for such purpose) or by any other method of allocation that does
not take account of the equitable considerations referred to in paragraph (d) above. The
amount paid or payable by an Indemnified Person as a result of the losses, claims, damages
and liabilities referred to in paragraph (d) above shall be deemed to include, subject to
the limitations set forth above, any legal or other expenses incurred by such Indemnified
Person in connection with any such action or claim. Notwithstanding the provisions of this
Section 7, in no event shall an Underwriter be required to contribute any amount in excess
of the amount by which the total underwriting discounts and commissions received by such
Underwriter with respect to the offering of the Shares exceeds the amount of any damages
that such Underwriter has otherwise been required to pay by reason of such untrue or alleged
untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters’ obligations to contribute pursuant to this Section 7
are several in proportion to their respective purchase obligations hereunder and not joint.
(g) Non-Exclusive Remedies. The remedies provided for in this Section 7 are not
exclusive and shall not limit any rights or remedies which may otherwise be available to any
Indemnified Person at law or in equity.
8. Effectiveness of Agreement. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto.
9. Termination. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company, if after the execution and delivery of this Agreement
and prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing
Date: (i) trading generally shall have been suspended or materially limited on or by any of the New
York Stock Exchange or the Nasdaq Stock Market; (ii) trading of any securities issued or guaranteed
by the Company shall have been suspended on any exchange or in any over-the-counter market; (iii) a
general moratorium on commercial banking activities shall have been declared by federal or New York
State authorities or a material disruption in commercial banking or securities settlement or
clearance services in the United States; or (iv) there shall have occurred any outbreak or
escalation of hostilities or any change in financial markets or any calamity or crisis, either
within or outside the United States, that, in the judgment of the Representatives, is material and
adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of
the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and
in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.
10. Defaulting Underwriter.
(a) If, on the Closing Date or the Additional Closing Date, as the case may be, any
Underwriter defaults on its obligation to purchase the Shares that it has agreed to purchase
hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for
the purchase of such Shares by other persons satisfactory to the Company on the terms
contained in this Agreement. If, within 36 hours after any such default by any Underwriter,
the non-defaulting Underwriters do not arrange for the purchase of such Shares, then the
Company shall be entitled to a further period of 36 hours within which to procure other
persons satisfactory to the non-defaulting Underwriters to purchase such Shares on such
terms. If other persons become obligated or agree to purchase the Shares of a defaulting
Underwriter, either the non-defaulting
26
Underwriters or the Company may postpone the Closing Date or the Additional Closing
Date, as the case may be, for up to five full business days in order to effect any changes
that in the opinion of counsel for the Company or counsel for the Underwriters may be
necessary in the Registration Statement and the Prospectus or in any other document or
arrangement, and the Company agrees to promptly prepare any amendment or supplement to the
Registration Statement and the Prospectus that effects any such changes. As used in this
Agreement, the term “Underwriter” includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to
this Section 10, purchases Shares that a defaulting Underwriter agreed but failed to
purchase.
(b) If, after giving effect to any arrangements for the purchase of the Shares of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on
the Closing Date or the Additional Closing Date, as the case may be, is equal to or less
than 10% of the aggregate number of Shares to be purchased on such date, then the Company
shall have the right to require each non-defaulting Underwriter to purchase the number of
Shares that such Underwriter agreed to purchase hereunder on such date plus such
Underwriter’s pro rata share (based on the number of Shares that such
Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or
Underwriters for which such arrangements have not been made.
(c) If, after giving effect to any arrangements for the purchase of the Shares of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on
the Closing Date or the Additional Closing Date, as the case may be, exceeds 10% of the
aggregate amount of Shares to be purchased on such date, or if the Company shall not
exercise the right described in paragraph (b) above, then this Agreement or, with respect to
any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the
Additional Closing Date shall terminate without liability on the part of the non-defaulting
Underwriters. Any termination of this Agreement pursuant to this Section 10 shall be
without liability on the part of the Company, except that the Company will continue to be
liable for the payment of expenses as set forth in Section 11 hereof and except that the
provisions of Section 7 hereof shall not terminate and shall remain in effect.
(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it
may have to the Company or any non-defaulting Underwriter for damages caused by its default.
11. Payment of Expenses.
(a) Whether or not the transactions contemplated by this Agreement are consummated or
this Agreement is terminated, the Company and/or the Operating Partnership will pay or cause
to be paid all costs and expenses incident to the performance of their obligations
hereunder, including without limitation: (i) the costs incident to the authorization,
issuance, sale, preparation and delivery of the Shares and any taxes payable in that
connection; (ii) the costs incident to the preparation, printing and filing under the
Securities Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free
Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all
exhibits, amendments and supplements thereto) and the distribution thereof; (iii) the costs
of reproducing and distributing each of the Transaction Documents; (iv) the fees and
expenses of the Company’s and the Operating Partnership’s counsel and independent
accountants; (v) the reasonable fees and expenses incurred in connection with the
registration or qualification of the Shares under the state or foreign securities or blue
sky laws of such
27
jurisdictions as the Representatives may designate and the preparation, printing and
distribution of a Blue Sky Memorandum (including the reasonable related fees and expenses of
counsel for the Underwriters); (vi) the cost of preparing stock certificates; (vii) the
costs and charges of any transfer agent and any registrar; (viii) all expenses and
application fees incurred in connection with any filing with, and clearance of the offering
by, FINRA (provided, however the Company and/or the Operating Partnership shall only be
responsible for the fees and expenses incurred under this subsection (viii) and subsection
(v) up to an aggregate amount of $30,000); (ix) all expenses incurred by the Company or the
Operating Partnership in connection with any “road show” presentation to potential
investors; and (x) all expenses and application fees related to the listing of the Shares on
the Exchange. Except as provided in this Agreement, the Underwriters shall pay their own
expenses, including the fees and disbursements of their counsel and advisers.
(b) If (i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any
reason fails to tender the Shares for delivery to the Underwriters or (iii) the Underwriters
decline to purchase the Shares for any reason permitted under this Agreement, the Company
agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the
fees and expenses of their counsel) reasonably incurred by the Underwriters in connection
with this Agreement and the offering contemplated hereby.
12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors and the officers
and directors and any controlling persons referred to in Section 7 hereof. Nothing in this
Agreement is intended or shall be construed to give any other person any legal or equitable right,
remedy or claim under or in respect of this Agreement or any provision contained herein. No
purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such
purchase.
13. Survival. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company, the Operating Partnership and the Underwriters contained
in this Agreement or made by or on behalf of the Company, the Operating Partnership or the
Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive
the delivery of and payment for the Shares and shall remain in full force and effect, regardless of
any termination of this Agreement or any investigation made by or on behalf of the Company, the
Operating Partnership or the Underwriters.
14. Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise
expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities
Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City and (c) the term “subsidiary” has the meaning set forth in
Rule 405 under the Securities Act.
15. Miscellaneous.
(a) Authority of the Representatives. Any action by the Underwriters hereunder may be
taken by the Representatives on behalf of the Underwriters, and any such action taken by the
Representatives shall be binding upon the Underwriters.
(b) Notices. All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly given if mailed or transmitted and confirmed by any
standard form of telecommunication. Notices to the Underwriters shall be given to Xxxxxxx
Xxxxx & Associates, Inc. at 000 Xxxxxxxx Xxxxxxx, Xx. Xxxxxxxxxx, Xxxxxxx 00000, attention
of General Counsel; Citigroup Global Markets Inc. General Counsel (fax no.: (000) 000-0000)
and
28
confirmed to the General Counsel, Citigroup Global Markets Inc., at 000 Xxxxxxxxx
Xxxxxx, Xxx Xxxx, Xxx Xxxx, 00000, Attention: General Counsel; Xxxxxxx, Sachs & Co. at 000
Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000-0000, Attention: Registration Department; Barclays
Capital Inc., 000 Xxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Syndicate
Registration (fax no.: (000) 000-0000), with a copy, in the case of any notice pursuant to
Section 7 hereof, to the Director of Litigation, Office of the General Counsel, Barclays
Capital Inc., 000 Xxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000; and to RBC Capital Markets
Corporation, Three World Financial Center, 8th Floor, 000 Xxxxx Xxxxxx, Xxx Xxxx,
Xxx Xxxx 00000, Attention: Xxx Xxxxx (fax no.: (000) 000-0000). Notices to the Company
shall be given to it at 2100 Xxxxxxx Road, Suite 414, Charlotte, North Carolina 00000 (000)
000-0000 (fax: (000) 000-0000); Attention: President and notices to the Operating
Partnership shall be given to Campus Crest Communities GP, LLC, the general partner of the
Operating Partnership, x/x Xxxxxx Xxxxx Xxxxxxxxxxx, Inc., 0000 Xxxxxxx Xxxx, Xxxxx 000,
Xxxxxxxxx, Xxxxx Xxxxxxxx 00000 (000) 000-0000 (fax: (000) 000-0000); Attention: President.
In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56
(signed into law October 26, 2001)), the Underwriters are required to obtain, verify and
record information that identifies their respective clients, including the Company, which
information may include the name and address of their respective clients, as well as other
information that will allow the Underwriters to properly identify their respective clients.
(c) Governing Law. This Agreement and any claim, controversy or dispute arising under
or related to this Agreement shall be governed by and construed in accordance with the laws
of the State of New York applicable to agreements made and to be performed in such state.
(d) Counterparts. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an
original and all of which together shall constitute one and the same instrument.
(e) Amendments or Waivers. No amendment or waiver of any provision of this Agreement,
nor any consent or approval to any departure therefrom, shall in any event be effective
unless the same shall be in writing and signed by the parties hereto.
(f) Headings. The headings herein are included for convenience of reference only and
are not intended to be part of, or to affect the meaning or interpretation of, this
Agreement.
29
If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below.
Very truly yours, CAMPUS CREST COMMUNITIES, INC. |
||||
By: | ||||
Name: | ||||
Title: | ||||
CAMPUS CREST COMMUNITIES OPERATING PARTNERSHIP, LP By Campus Crest Communities GP, LLC, its general partner |
||||
By: | ||||
Name: | ||||
Title: | ||||
Accepted: , 2010 | ||||
XXXXXXX XXXXX & ASSOCIATES, INC. | ||||
By: |
||||
Authorized Signatory | ||||
CITIGROUP GLOBAL MARKETS INC. | ||||
By: |
||||
Authorized Signatory | ||||
XXXXXXX, SACHS & CO. | ||||
By: |
||||
Authorized Signatory | ||||
BARCLAYS CAPITAL INC. | ||||
By: |
||||
Authorized Signatory | ||||
RBC CAPITAL MARKETS CORPORATION | ||||
By: |
||||
Authorized Signatory |
For themselves and on behalf of the several Underwriters listed in Schedule 1 hereto.
30
Schedule 1
Underwriter | Number of Shares | |||
Xxxxxxx Xxxxx & Associates, Inc. |
||||
Citigroup Global Markets Inc. |
||||
Xxxxxxx, Sachs & Co. |
||||
Barclays Capital Inc. |
||||
RBC Capital Markets Corporation |
||||
Xxxxxx X. Xxxxx & Co. Incorporated |
||||
Total |
||||
Annex A
Form of Opinion of Xxxxxxx Xxxxx Boult Xxxxxxxx LLP
(a) The Registration Statement, including any Rule 462(b) Registration Statement, was declared
effective under the Securities Act as of the date and time specified in such opinion; each of the
Preliminary Prospectus and the Prospectus was filed with the Commission pursuant to the
subparagraph of Rule 424(b) under the Securities Act specified in such opinion (without reference
to Rule 424(b)(8)) on the date specified therein; any required filing of each Issuer Free Writing
Prospectus pursuant to Rule 433 under the Securities Act has been filed with the Commission within
the time period required pursuant to Rule 433(d) under the Securities Act; and no order suspending
the effectiveness of the Registration Statement has been issued and no proceeding for that purpose
or pursuant to Section 8A of the Securities Act against the Company or in connection with the
offering is pending or, to the knowledge of such counsel, threatened by the Commission.
(b) The Registration Statement, including any Rule 462(b) Registration Statement, the
Preliminary Prospectus, each Issuer Free Writing Prospectus included in the Pricing Disclosure
Package and the Prospectus (other than the financial statements and related schedules therein, as
to which such counsel need express no opinion) comply as to form in all material respects with the
requirements of the Securities Act.
(c) The Company is a corporation duly organized and validly existing under and by virtue of
the laws of the State of Maryland and is in good standing with the State Department of Assessments
and Taxation of Maryland (the “SDAT”).
(d) The Operating Partnership has been duly organized and is validly existing as a limited
partnership in good standing under the laws of state of Delaware.
(e) The Operating Partnership has the partnership power and authority to own, lease, develop
and operate its properties and to conduct its business as described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus and to enter into and perform its obligations
under the Underwriting Agreement and the Transaction Documents. Except as otherwise stated in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, all of the outstanding
equity interests of the Operating Partnership have been duly authorized for issuance by the
Operating Partnership and are validly issued.
(f) Each of the Company and the Operating Partnership is duly qualified as a foreign
corporation and a limited partnership, respectively, to transact business and is in good standing
in each jurisdiction in which such qualification is required, whether by reason of the ownership or
leasing of property or the conduct of business, except where the failure so to qualify or to be in
good standing would not result in a Material Adverse Effect.
(g) To the knowledge of such counsel, each Significant Subsidiary has been duly organized and
is validly existing and in good standing under the laws of its respective jurisdiction of
organization, is duly qualified to do business and is in good standing in each jurisdiction in
which its respective ownership or lease of property or the conduct of its respective business
requires such qualification (except where the failure to so qualify or to be in good standing would
not result in a Material Adverse Effect), has all corporate or entity power and authority necessary
to own, lease, develop or operate its respective properties and to conduct the business in which it
is engaged; except as otherwise disclosed in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, to the best of our knowledge,
A-1-1
all of the issued and outstanding capital stock of each Significant Subsidiary has been duly
authorized and validly issued, is fully paid and non assessable and is owned by the Company or the
Operating Partnership, directly or through subsidiaries, free and clear of any security interest,
mortgage, pledge, lien, encumbrance, claim or equity; none of the outstanding shares of capital
stock or any other equity interests of any subsidiary was issued in violation of the preemptive or
similar rights of any securityholder of such subsidiary.
(h) The Underwriting Agreement has been duly executed and delivered by the Company.
(i) The Underwriting Agreement has been duly authorized, executed and delivered by the
Operating Partnership.
(j) The Transaction Documents have been duly executed and delivered by the Company and
assuming the due authorization thereof and the execution and delivery by each of the other parties
thereto, constitute valid and legally binding agreements of the Company, enforceable against the
Company in accordance with their terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, fraudulent conveyance or similar laws affecting creditors’ rights generally
or by equitable principles relating to enforceability.
(k) The Transaction Documents have been duly authorized, executed and delivered by the
Operating Partnership and assuming the execution and delivery by each of the other parties thereto,
constitute valid and legally binding agreements of the Operating Partnership, enforceable against
the Operating Partnership in accordance with their terms, except as enforceability may be limited
by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting creditors’
rights generally or by equitable principles relating to enforceability.
(l) The issuance and sale by the Operating Partnership of the OP Units in connection with the
contribution of the certain ownership interests in the Initial Properties to the Operating
Partnership are exempt from the registration requirements of the Securities Act and applicable
state securities, real estate syndication and blue sky laws.
(m) Each Transaction Document conforms in all material respects to the description thereof
contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
(n) All descriptions in the Registration Statement, the Pricing Disclosure Package and the
Prospectus of contracts and other documents to which the Company, the Operating Partnership or any
of their subsidiaries are a party are accurate in all material respects.
(o) The execution, delivery and performance by the Company and the Operating Partnership of
the Underwriting Agreement, of each of the Transaction Documents, the compliance by the Company and
the Operating Partnership with the terms of the Underwriting Agreement and the Transaction
Documents, the issuance and sale of the Shares being delivered on the Closing Date or the
Additional Closing Date, as the case may be, and the consummation of the transactions contemplated
by the Underwriting Agreement and the Transaction Documents will not (i) to the best of our
knowledge, conflict with or result in a breach or violation of any of the terms or provisions of,
or constitute a default under, or result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company, the Operating Partnership or any of their
subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement
or instrument to which the Company, the Operating Partnership or any of their subsidiaries is a
party or by which the Company, the Operating Partnership or any of their subsidiaries is bound or
to which any of the property or assets of the Company, the Operating Partnership or any of their
subsidiaries is subject, (ii) result in any violation of the
A-1-2
provisions of the charter or by-laws or similar organizational documents of the Company, the
Operating Partnership or any of their subsidiaries or (iii) to the best of our knowledge, result in
the violation of any law or statute or any judgment, order or regulation of any court or arbitrator
or governmental or regulatory authority except, in the case of clauses (i) and (iii) above, for
such conflict, breach, violation or default that is disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus and for which a valid waiver has been obtained or
that would not, individually or in the aggregate, have a Material Adverse Effect.
(p) No consent, approval, authorization, order, registration or qualification of or with any
court or arbitrator or governmental or regulatory authority is required for the execution, delivery
and performance by the Company or the Operating Partnership of the Underwriting Agreement, of each
of the Transaction Documents, the compliance by the Company or the Operating Partnership with the
terms of the Underwriting Agreement or the Transaction Documents, the issuance and sale of the
Shares being delivered on the Closing Date or the Additional Closing Date, as the case may be, and
the consummation of the transactions contemplated by the Underwriting Agreement and the Transaction
Documents, except for the registration of the Shares under the Securities Act and such consents,
approvals, authorizations, orders and registrations or qualifications as may be required under
applicable state securities laws in connection with the purchase and distribution of the Shares by
the Underwriters.
(q) To the knowledge of such counsel, except as described in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, there are no legal, governmental or regulatory
investigations, actions, suits or proceedings pending to which the Company, the Operating
Partnership or any of their subsidiaries is or may be a party or to which any property of the
Company, the Operating Partnership or any of their subsidiaries is or may be the subject which,
individually or in the aggregate, if determined adversely to the Company, the Operating Partnership
or any of their subsidiaries, could reasonably be expected to have a Material Adverse Effect; and
to the knowledge of such counsel, no such investigations, actions, suits or proceedings are
threatened or contemplated by any governmental or regulatory authority or threatened by others.
(r) The descriptions in the Registration Statement, the Pricing Disclosure Package and the
Prospectus of statutes, legal, governmental and regulatory proceedings and contracts and other
documents are accurate in all material respects; the statements in the Preliminary Prospectus and
Prospectus under the headings “Risk Factors—Federal Income Tax Risk Factors,” “Shares Eligible for
Future Sale,” “Description of Our Operating Partnership,” “Federal Income Tax Considerations,” and
“ERISA Considerations” to the extent that they constitute summaries of matters of law or regulation
or legal conclusions, fairly summarize the matters described therein in all material respects; and,
to the knowledge of such counsel, (A) there are no current or pending legal, governmental or
regulatory actions (excluding pending rulemaking), suits or proceedings that are required under the
Securities Act to be described in the Registration Statement or the Prospectus and that are not so
described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and (B)
there are no statutes, regulations or contracts and other documents that are required under the
Securities Act to be filed as exhibits to the Registration Statement or described in the
Registration Statement or the Prospectus and that have not been so filed as exhibits to the
Registration Statement or described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus.
(s) After giving effect to the application of the proceeds from the offering and sale of the
Shares as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, neither the Company nor the Operating Partnership will be required to register as an
“investment company” or an entity “controlled” by an “investment company” within the meaning of the
Investment Company Act.
A-1-3
(t) To such counsel’s knowledge, except as described in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, there are no persons with registration rights or
other similar rights to have any securities registered pursuant to the Registration Statement or
otherwise registered by the Company under the Securities Act.
(u) Commencing with the Company’s taxable year ending December 31, 2010, the Company will be
organized in conformity with the requirements for qualification as a real estate investment trust
(a “REIT”) under the Code and the Company’s proposed method of operation as set forth in the
Registration Statement, the Pricing Disclosure Package and the Prospectus will enable the Company
to continue to meet the requirements for qualification and taxation as a REIT for its taxable years
ending after December 31, 2010.
(v) Such counsel shall also state that they have participated in conferences with
representatives of the Company and the Operating Partnership and with representatives of its
independent accountants and counsel at which conferences the contents of the Registration
Statement, the Pricing Disclosure Package and the Prospectus and any amendment and supplement
thereto and related matters were discussed and, although such counsel assume no responsibility for
the accuracy, completeness or fairness of the Registration Statement, the Pricing Disclosure
Package, the Prospectus and any amendment or supplement thereto (except as expressly provided
above), nothing has come to the attention of such counsel to cause such counsel to believe that the
Registration Statement, at the time of its effective date (including the information, if any,
deemed pursuant to Rule 430A, 430B or 430C to be part of the Registration Statement at the time of
effectiveness), contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements therein not misleading, that
the Pricing Disclosure Package, as of the Applicable Time (which such counsel may assume to be the
date of the Underwriting Agreement) contained any untrue statement of a material fact or omitted to
state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading or that the Prospectus or any amendment or supplement
thereto as of its date and the Closing Date contains any untrue statement of a material fact or
omits to state a material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading (other than the financial statements and
other financial information contained therein, as to which such counsel need express no belief).
In rendering such opinion, such counsel may rely as to matters of fact on certificates of
responsible officers of the Company and the Operating Partnership and public officials that are
furnished to the Underwriters.
The opinion of Xxxxxxx Xxxxx Boult Xxxxxxxx LLP described above shall be rendered to the
Underwriters at the request of the Company and the Operating Partnership and shall so state
therein.
X-0-0
Xxxxx X-0
Form of Opinion of Xxxx Xxxxx LLP
(a) The Company is a corporation duly organized and validly existing under and by virtue of
the laws of the State of Maryland and is in good standing with the SDAT, with corporate power to
carry on its business and to own, lease, develop and operate its properties, in all material
respects as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus.
(b) The authorized, issued and outstanding shares of common stock in the Company are as set
forth in the Prospectus under the caption “Capitalization” (except for subsequent issuances, if
any, pursuant to the Underwriting Agreement or the equity incentive share plan referred to in the
Prospectus); the issued and outstanding shares of common stock in the Company have been duly
authorized and validly issued and are fully paid and non assessable; and none of the outstanding
shares of common stock in the Company was issued in violation of (a) the charter or the bylaws of
the Company or (b) any Maryland law, rule or regulation (other than any law, rule or regulation in
connection with the securities laws of the State of Maryland, as to which we express no opinion).
(c) The form of certificate used to evidence the common stock complies in all material
respects with the Maryland General Corporation Law, and with any applicable requirements of the
Company’s charter and bylaws.
(d) The Company has the corporate power to execute, deliver and perform its obligations under
the Underwriting Agreement and the Transaction Documents and to issue and deliver the Shares in
accordance with and upon the terms and conditions set forth in the Underwriting Agreement. The
execution and delivery of the Underwriting Agreement and the Transaction Documents and the
performance by the Company of its obligations thereunder have been duly authorized by the Company.
The Underwriting Agreement and the Transaction Documents have been duly executed and, to such
counsel’s knowledge, delivered by the Company.
(e) The sale and issuance of the Shares to the Underwriters pursuant to the Underwriting
Agreement have been duly authorized by all necessary corporate action of the Company and, when
issued and delivered by the Company pursuant to the Underwriting Agreement against payment of the
consideration set forth therein, the Shares will be validly issued, fully paid and nonassessable
and are not subject to preemptive rights to purchase or subscribe for shares of beneficial interest
in the Company arising under the Maryland General Corporation Law, the Company’s charter or the
Company’s bylaws in connection with the issuance of the Shares and no holder of the Shares is or
will be subject to personal liability solely by reason of being such a holder.
(f) The execution, delivery and performance by the Company of the Underwriting Agreement and
the consummation by the Company of the transactions contemplated in the Underwriting Agreement and
in the Registration Statement, the Pricing Disclosure Package and the Prospectus (including the
issuance and sale of the Shares and the use of the proceeds from the sale of the Shares as
described in the Prospectus under the caption “Use Of Proceeds”) and the compliance by the Company
with its obligations under the Underwriting Agreement do not and will not, whether with or without
the giving of notice or lapse of time or both, result in any violation of (a) the charter or the
bylaws of the Company or (b) any Maryland law, rule or regulation (other than any law, rule or
regulation in connection with the securities laws of the State of Maryland, as to which we express
no opinion).
A-2-1
(g) Except for such consents, approvals, authorizations, registrations or qualifications, if
any, as may be required under the securities laws of the State of Maryland (as to which we express
no opinion) in connection with the offering and sale of the Shares, no approval, authorization,
consent or order of, or filing with, any Maryland governmental authority is required in connection
with the authorization, execution and delivery by the Company of the Underwriting Agreement and the
consummation by the Company of the transactions contemplated thereby or for the offering, issuance,
sale or delivery of the Shares by the Company.
(h) To such counsel’s knowledge, the Company is not in violation of its charter or bylaws.
(i) The information in the Pricing Disclosure Package and the Prospectus under the captions
“Risk Factors—Risks Related to Our Company and Structure,” “Description of Capital Stock,”
“Policies with Respect to Certain Activities—Conflicts of Interest Policies—Interested Director
and Officer Transactions” and “Certain Provisions of Maryland Law and of our Charter and Bylaws” as
of the date of thereof and as of the date hereof, and in the Registration Statement under Item 34,
insofar as such information relates to provisions of the Company’s charter, the Company’s bylaws or
Maryland law, fairly summarizes such provisions in all material respects.
The opinion of Xxxx Xxxxx LLP described above shall state that it may be relied upon
by Sidley Austin LLP as to matters arising under Maryland law.
A-2-2
Annex B
PRICING DISCLOSURE PACKAGE
B-1
Annex C
INITIAL PROPERTIES
1. | The Grove at Asheville (Asheville, NC) |
2. | The Grove at Carrollton (Carrollton, GA) |
3. | The Grove at Las Cruces (Las Cruces, NM) |
4. | The Grove at Milledgeville (Milledgeville, GA) |
5. | The Grove at Abilene (Abilene, TX) |
6. | The Grove at Ellensburg (Ellensburg, WA) |
7. | The Grove at Greeley (Evans, CO) |
8. | The Grove at Jacksonville (Jacksonville, AL) |
9. | The Grove at Mobile — Phase I (Mobile, AL) |
10. | The Grove at Mobile — Phase II (Mobile, AL) |
11. | The Grove at Nacogdoches (Nacogdoches, TX) |
12. | Xxx Xxxxx xx Xxxxxx (Xxxxxx, XX) |
13. | The Grove at Jonesboro (Jonesboro, AR) |
14. | The Grove at Lubbock (Lubbock, TX) |
15. | The Grove at Stephenville (Stephenville, TX) |
16. | The Grove at Xxxx (Troy, AL) |
17. | The Grove at Waco (Waco, TX) |
18. | The Grove at Wichita (Wichita, KS) |
19. | The Grove at Wichita Falls (Wichita Falls, TX) |
20. | The Grove at Murfreesboro (Murfreesboro, TN) |
21. | The Grove at San Marcos (San Marcos, TX) |
22. | The Grove at Lawrence (Lawrence, KS) |
23. | The Grove at Moscow (Moscow, ID) |
24. | The Grove at San Xxxxxx (San Angelo, TX) |
25. | The Grove at Xxxxxx (Conway, AR) |
26. | The Grove at Huntsville (Huntsville, TX) |
27. | The Grove at Statesboro (Statesboro, GA) |
C-1
Annex D
TRANSACTION DOCUMENTS
1. | Campus Crest Communities, Inc. Equity Incentive Compensation Plan. |
2. | Form of Indemnification Agreement. |
3. | Employment Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxx X. Xxxxxxx. |
4. | Employment Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxxxxx X. Xxxxxxxx. |
5. | Employment Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxx X. Xxxxxx. |
6. | Employment Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxxxx X. Xxxxxxx, Xx. |
7. | Employment Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxxxxx X. Xxxx. |
8. | Confidentiality and Noncompetition Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxx X. Xxxxxxx. |
9. | Confidentiality and Noncompetition Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxxxxx X. Xxxxxxxx. |
10. | Confidentiality and Noncompetition Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxx X. Xxxxxx. |
11. | Confidentiality and Noncompetition Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxxxx X. Xxxxxxx, Xx. |
12. | Confidentiality and Noncompetition Agreement by and between Campus Crest Communities Operating Partnership, LP and Xxxxxxx X. Xxxx. |
13. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and MXT Capital, LLC, dated May 13, 2010. |
14. | Amendment No. 1 to Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and MXT Capital, LLC, dated , 2010 |
15. | Tax Protection Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and MXT Capital, LLC. |
16. | Registration Rights Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, MXT Capital, LLC and certain other parties thereto. |
D-1
17. | Credit Agreement for Senior Secured Revolving Credit Facility by and among Campus Crest Communities Operating Partnership, LP, Citibank, N.A. and certain other parties thereto. |
18. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxx X. Xxxxxx, Xx., dated May 13, 2010. |
19. | First Amendment to Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxx X. Xxxxxx, Xx., dated September 14, 2010. |
20. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxx Development, LLC, dated April 22, 2010. |
21. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Mansion Ridge Investment Company, LLC, dated May 6, 2010. |
22. | Purchase and Sale Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Highland Park, LLC, dated May 13, 2010. |
23. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxx Xxxxxxx, dated May 1, 2010. |
24. | Purchase and Sale Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and P. Xxxxxx Xxxxxx, dated May 13, 2010. |
25. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxx X. Xxxxxx, XX, dated April 19, 2010. |
26. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and BGY, LLC, dated April 15, 2010. |
27. | Purchase and Sale Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxx X. Xxxxxxxxx, dated May 13, 2010. |
28. | Purchase and Sale Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxxxx Xxxxxx Xxxxx, dated May 13, 2010. |
29. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxx Xxxxxx, dated May 10, 2010. |
30. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and X.X. Xxxxxx, III, dated April 29, 2010. |
31. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and NLR-Cotton Valley Investment, LLC, dated April 19, 2010. |
32. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxxxx Xxxxx Association Endowment Fund, dated May 4, 2010. |
X-0
00. | Xxxxxxxx and Sale by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxx X. Xxxxxxx, dated May 9, 2010. |
34. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxxxxx-Xxxx Investments, LLC, dated April 19, 2010. |
35. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP, and Xxxxxxx X. X’Xxxxxx, dated May 6, 2010. |
36. | Purchase and Sale Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP and certain other parties thereto, dated March 26, 2010. |
37. | Contribution Agreement by and among Campus Crest Communities, Inc., Campus Crest Communities Operating Partnership, LP and Xxxxxx X. Xxxx dated May 13, 2010. |
38. | Ground Lease by and between USA Research and Technology Corporation and Campus Crest at Mobile, LLC, dated August 8, 2006. |
39. | Ground Lease by and between USA Research and Technology Corporation and Campus Crest at Mobile Phase II, LLC, dated March 14, 2008. |
40. | Ground Lease Agreement by and between Indian Hills Trading Company, LLC and Campus Crest Development, LLC, dated March 20, 2008. |
41. | First Amendment to Ground Lease Agreement by and between Indian Hills Trading Company, LLC and Campus Crest Development, LLC, dated July 28, 2008. |
42. | Assignment of Ground Lease Agreement and Purchase Option Agreement by Campus Crest Development, LLC and Campus Crest at Moscow, LLC, dated July 28, 2008. |
43. | Loan Agreement between General Electric Capital Corporation and Campus Crest at Milledgeville, LLC, dated September 7, 2006. |
44. | Deed to Secure Debt, Security Agreement and Fixture Filing by Campus Crest at Carrollton, LLC to Wachovia Bank, National Association, dated September 18, 2006. |
45. | Deed of Trust, Security Agreement and Fixture Filing by Campus Crest at Las Cruces, LLC for the benefit of Wachovia Bank, National Association, dated September 22, 2006. |
46. | Deed of Trust, Security Agreement and Fixture Filing by Campus Crest at Asheville, LLC for the benefit of Wachovia Bank, National Association, dated March 13, 2007. |
47. | Loan Agreement by and among Campus Crest at Mobile, LLC, Campus Crest at Jacksonville, AL, LLC, Campus Crest at Nacogdoches, LP, Campus Crest at Abilene, LP, Campus Crest at Greeley, LLC, and Campus Crest at Ellensburg, LLC, and Silverton Bank, N.A., dated February 29, 2008. |
48. | Transfer, Assignment and Assumption Agreement by and among the Federal Deposit Insurance Corporation as receiver and successor-in-interest to Silverton Bank, N.A. and Campus Crest Loan Servicing, LLC, dated March 31, 2010. |
X-0
00. | Construction Loan Agreement by and among Wachovia Bank, National Association, Campus Crest Group, LLC, Campus Crest at Moscow, LLC, Campus Crest at San Xxxxxx, LP and Campus Crest at San Marcos, LP, dated November 18, 2008. |
50. | First Amendment to Construction Loan Agreement by and among Wachovia Bank, National Association, Campus Crest Group, LLC, Campus Crest at Moscow, LLC, Campus Crest at San Xxxxxx, LP and Campus Crest at San Marcos, LP, dated June 2009. |
51. | Construction Loan Agreement by and between Campus Crest at Xxxxxxxx, LLC and Mutual of Omaha Bank, dated February 13, 2009. |
52. | First Amendment to Construction Loan Agreement by and between Campus Crest at Xxxxxxxx, LLC and Mutual of Omaha Bank, dated March 19, 2009. |
53. | Construction Loan Agreement by and between Amegy Mortgage Company, L.L.C. d/b/a Q-10 Amegy Mortgage Capital and Campus Crest at Huntsville, LP, dated June 12, 2009. |
54. | Secured Construction Loan Agreement by and between Centennial Bank, F/K/A First State Bank and Campus Crest at Xxxxxx, LLC, dated July 2, 2009. |
55. | Construction Loan Agreement by and between Campus Crest at Statesboro, LLC and The Private Bank and Trust Company, dated November 12, 2009. |
56. | Operating Agreement of HSRE-Campus Crest I, LLC, dated as of November 7, 2008. |
57. | First Amendment to the Operating Agreement of HSRE-Campus Crest I, LLC, dated as of November 12, 2009. |
58. | Second Amendment to the Operating Agreement of HSRE-Campus Crest I, LLC, dated March 26, 2010. |
59. | Third Amendment to the Operating Agreement of HSRE-Campus Crest I, LLC, dated [•]. |
60. | Form of Aircraft Lease. |
D-1
Exhibit A
FORM OF LOCK-UP AGREEMENT
, 20__
Xxxxxxx Xxxxx & Associates, Inc.
000 Xxxxxxxx Xxxxxxx
Xx. Xxxxxxxxxx, Xxxxxxx 00000
000 Xxxxxxxx Xxxxxxx
Xx. Xxxxxxxxxx, Xxxxxxx 00000
Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxxx, Sachs & Co.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Barclays Capital Inc.
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
RBC Capital Markets Corporation
Three World Financial Center, 8th Floor
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Three World Financial Center, 8th Floor
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
As Representatives of the
several Underwriters listed in Schedule 1
to the within mentioned Underwriting Agreement
several Underwriters listed in Schedule 1
to the within mentioned Underwriting Agreement
Re: Campus Crest Communities, Inc. — Public Offering
Ladies and Gentlemen:
The undersigned understands that you, as Representatives of the several Underwriters, propose
to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Campus Crest
Communities, Inc., a Maryland corporation (the “Company”) and Campus Crest Communities Operating
Partnership, LP, a Delaware limited partnership and the operating partnership of the Company (in
such capacity, the “Operating Partnership”), providing for the public offering (the “Public
Offering”) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the
“Underwriters”), of common stock, par value $0.01 per share, of the Company (the “Common Stock”).
Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the
Underwriting Agreement.
In consideration of the Underwriters’ agreement to purchase and make the Public Offering of
the common stock, and for other good and valuable consideration receipt of which is hereby
acknowledged, the undersigned hereby agrees that, without the prior written consent of the
Representatives, the undersigned will not, during the period ending one year after the date of the
prospectus relating to the Public Offering (the “Prospectus”), directly or indirectly, (i) offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant for the sale of, or lend or otherwise dispose
of or transfer any Common Stock or any securities convertible into or
Ex. A-1
exchangeable or exercisable
for or repayable with Common Stock, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires
the power of disposition, or file, or cause to be filed, any registration statement under the
Securities Act of 1933, as amended, with respect to any of the foregoing (collectively, the
“Lock-Up Securities”) or (ii) enter into any swap or any other agreement or any transaction that
transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of
the Lock-Up Securities, whether any such swap, agreement or transaction is to be settled by
delivery of Common Stock or other securities, in cash or otherwise.
Notwithstanding the foregoing, and subject to the conditions below, the undersigned may
transfer the Lock-Up Securities without the prior written consent of the Representatives, provided
that (1) the Representatives receive a signed lock-up agreement for the balance of the lock-up
period from each donee or trustee, as the case may be, (2) any such transfer shall not involve a
disposition for value, (3) such transfers are not required to be reported in any public report or
filing with the Securities and Exchange Commission, or otherwise and (4) the undersigned does not
otherwise voluntarily effect any public filing or report regarding such transfers:
(i) as a bona fide gift or gifts; or
(ii) to any trust for the direct or indirect benefit of the undersigned or the
immediate family of the undersigned (for purposes of this lock-up agreement, “immediate
family” shall mean any relationship by blood, marriage or adoption, not more remote than
first cousin).
Furthermore, the undersigned may sell shares of Common Stock of the Company purchased by the
undersigned on the open market following the Public Offering if and only if (i) such sales are not
required to be reported in any public report or filing with the Securities Exchange Commission, or
otherwise, and (ii) the undersigned does not otherwise voluntarily effect any public filing or
report regarding such sales.
Notwithstanding the foregoing, if: (1) during the last 17 days of the one year period, the
Company issues an earnings release or material news or a material event relating to the Company
occurs; or (2) prior to the expiration of the one year restricted period, the Company announces
that it will release earnings results or becomes aware that material news or a material event
relating to the Company will occur during the 16-day period beginning on the last day of the one
year period, the restrictions imposed by this lock-up agreement shall continue to apply until the
expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence
of the material news or material event.
In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the
registration or transfer of the securities described herein, are hereby authorized to decline to
make any transfer of securities if such transfer would constitute a violation or breach of this
lock-up agreement.
The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this lock-up agreement. All authority herein conferred or agreed to be
conferred and any obligations of the undersigned shall be binding upon the successors, assigns,
heirs or personal representatives of the undersigned.
The undersigned understands that, if the Underwriting Agreement does not become effective, or
if the Underwriting Agreement (other than the provisions thereof which survive termination) shall
terminate or be terminated prior to payment for and delivery of the Common Stock to be sold
thereunder, the undersigned shall be released from, all obligations under this lock-up agreement.
The undersigned understands that the Underwriters are entering into the Underwriting Agreement and
proceeding with the Public Offering in reliance upon this lock-up agreement.
Ex. A-2
This lock-up agreement and any claim, controversy or dispute arising under or related to this
lock-up agreement shall be governed by and construed in accordance with the laws of the State of
New York, without regard to the conflict of laws principles thereof.
Very truly yours, [NAME OF STOCKHOLDER] |
||||
By: | ||||
Name: | ||||
Title: | ||||
Ex. A-3
Exhibit B
PERSONS AND ENTITIES SUBJECT TO LOCK-UP
Xxx X. Xxxxxxx
Xxxxxxx X. Xxxxxxxx
Xxxx X. Xxxxxx
Xxxxxx X. Xxxxxxx, Xx.
Xxxxxxx X. Xxxx
Xxxxxxx X. Xxxxxxxxx
Xxxxx XxXxxxx
Xxxxxx X. Xxxxxxx
Xxxxxxx X. Xxxxx
N. Xxxxxxx Xxxxx
Xxxxx X. Xxxxxx
Xxxxxx X. Xxxxxxxx
MXT Capital, LLC
Madeira Group, LLC
TXG, LLC
Xxxx X. Xxxxxx, Xx.
Xxxxxxx X. Xxxxxxxx
Xxxx X. Xxxxxx
Xxxxxx X. Xxxxxxx, Xx.
Xxxxxxx X. Xxxx
Xxxxxxx X. Xxxxxxxxx
Xxxxx XxXxxxx
Xxxxxx X. Xxxxxxx
Xxxxxxx X. Xxxxx
N. Xxxxxxx Xxxxx
Xxxxx X. Xxxxxx
Xxxxxx X. Xxxxxxxx
MXT Capital, LLC
Madeira Group, LLC
TXG, LLC
Xxxx X. Xxxxxx, Xx.
Ex. B-1